<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2023-02-23T14:49:16Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:8773224" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:8773224</identifier>
        <datestamp>2022-01-21</datestamp>
        <setSpec>biomedicines</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Biomedicines</journal-id>
              <journal-id journal-id-type="iso-abbrev">Biomedicines</journal-id>
              <journal-id journal-id-type="publisher-id">biomedicines</journal-id>
              <journal-title-group>
                <journal-title>Biomedicines</journal-title>
              </journal-title-group>
              <issn pub-type="epub">2227-9059</issn>
              <publisher>
                <publisher-name>MDPI</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC8773224</article-id>
              <article-id pub-id-type="pmcid">PMC8773224</article-id>
              <article-id pub-id-type="pmc-uid">8773224</article-id>
              <article-id pub-id-type="pmid">35052817</article-id>
              <article-id pub-id-type="doi">10.3390/biomedicines10010138</article-id>
              <article-id pub-id-type="publisher-id">biomedicines-10-00138</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Retrograde Analysis of Calcium Signaling by CaMPARI2 Shows Cytosolic Calcium in Chondrocytes Is Unaffected by Parabolic Flights</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Hammer</surname>
                    <given-names>Andreas</given-names>
                  </name>
                  <xref rid="af1-biomedicines-10-00138" ref-type="aff">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Cerretti</surname>
                    <given-names>Geraldine</given-names>
                  </name>
                  <xref rid="af2-biomedicines-10-00138" ref-type="aff">2</xref>
                  <xref rid="af3-biomedicines-10-00138" ref-type="aff">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-0543-0897</contrib-id>
                  <name>
                    <surname>Ricciardi</surname>
                    <given-names>Dario A.</given-names>
                  </name>
                  <xref rid="af1-biomedicines-10-00138" ref-type="aff">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Schiffmann</surname>
                    <given-names>David</given-names>
                  </name>
                  <xref rid="af4-biomedicines-10-00138" ref-type="aff">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Maranda</surname>
                    <given-names>Simon</given-names>
                  </name>
                  <xref rid="af4-biomedicines-10-00138" ref-type="aff">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Kummer</surname>
                    <given-names>Raphael</given-names>
                  </name>
                  <xref rid="af5-biomedicines-10-00138" ref-type="aff">5</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Zumbühl</surname>
                    <given-names>Christoph</given-names>
                  </name>
                  <xref rid="af5-biomedicines-10-00138" ref-type="aff">5</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Rattenbacher-Kiser</surname>
                    <given-names>Karin F.</given-names>
                  </name>
                  <xref rid="af2-biomedicines-10-00138" ref-type="aff">2</xref>
                  <xref rid="af3-biomedicines-10-00138" ref-type="aff">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>von Arx</surname>
                    <given-names>Silvan</given-names>
                  </name>
                  <xref rid="af4-biomedicines-10-00138" ref-type="aff">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Ammann</surname>
                    <given-names>Sebastian</given-names>
                  </name>
                  <xref rid="af4-biomedicines-10-00138" ref-type="aff">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Strobl</surname>
                    <given-names>Frederic</given-names>
                  </name>
                  <xref rid="af6-biomedicines-10-00138" ref-type="aff">6</xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-0705-2298</contrib-id>
                  <name>
                    <surname>Berkane</surname>
                    <given-names>Rayene</given-names>
                  </name>
                  <xref rid="af6-biomedicines-10-00138" ref-type="aff">6</xref>
                  <xref rid="af7-biomedicines-10-00138" ref-type="aff">7</xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-3340-439X</contrib-id>
                  <name>
                    <surname>Stolz</surname>
                    <given-names>Alexandra</given-names>
                  </name>
                  <xref rid="af6-biomedicines-10-00138" ref-type="aff">6</xref>
                  <xref rid="af7-biomedicines-10-00138" ref-type="aff">7</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Stelzer</surname>
                    <given-names>Ernst H. K.</given-names>
                  </name>
                  <xref rid="af6-biomedicines-10-00138" ref-type="aff">6</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Egli</surname>
                    <given-names>Marcel</given-names>
                  </name>
                  <xref rid="af2-biomedicines-10-00138" ref-type="aff">2</xref>
                  <xref rid="af3-biomedicines-10-00138" ref-type="aff">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-0518-3489</contrib-id>
                  <name>
                    <surname>Schleiff</surname>
                    <given-names>Enrico</given-names>
                  </name>
                  <xref rid="af1-biomedicines-10-00138" ref-type="aff">1</xref>
                  <xref rid="c1-biomedicines-10-00138" ref-type="corresp">*</xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-5495-6951</contrib-id>
                  <name>
                    <surname>Wuest</surname>
                    <given-names>Simon L.</given-names>
                  </name>
                  <xref rid="af2-biomedicines-10-00138" ref-type="aff">2</xref>
                  <xref rid="af3-biomedicines-10-00138" ref-type="aff">3</xref>
                  <xref rid="fn1-biomedicines-10-00138" ref-type="author-notes">†</xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-6675-273X</contrib-id>
                  <name>
                    <surname>Böhmer</surname>
                    <given-names>Maik</given-names>
                  </name>
                  <xref rid="af1-biomedicines-10-00138" ref-type="aff">1</xref>
                  <xref rid="c1-biomedicines-10-00138" ref-type="corresp">*</xref>
                  <xref rid="fn1-biomedicines-10-00138" ref-type="author-notes">†</xref>
                </contrib>
              </contrib-group>
              <contrib-group>
                <contrib contrib-type="editor">
                  <name>
                    <surname>Grimm</surname>
                    <given-names>Daniela</given-names>
                  </name>
                  <role>Academic Editor</role>
                </contrib>
                <contrib contrib-type="editor">
                  <name>
                    <surname>Hemmersbach</surname>
                    <given-names>Ruth</given-names>
                  </name>
                  <role>Academic Editor</role>
                </contrib>
              </contrib-group>
              <aff id="af1-biomedicines-10-00138"><label>1</label>Institute for Molecular Biosciences, Johann Wolfgang Goethe Universität, 60438 Frankfurt am Main, Germany; <email>hammer@bio.uni-frankfurt.de</email> (A.H.); <email>Ricciardi@bio.uni-frankfurt.de</email> (D.A.R.)</aff>
              <aff id="af2-biomedicines-10-00138"><label>2</label>Space Biology Group, Institute of Medical Engineering, School of Engineering and Architecture, Lucerne University of Applied Sciences and Arts, 6052 Hergiswil, Switzerland; <email>geraldine.cerretti@hslu.ch</email> (G.C.); <email>karin.rattenbacher@hslu.ch</email> (K.F.R.-K.); <email>marcel.egli@hslu.ch</email> (M.E.); <email>simon.wueest@hslu.ch</email> (S.L.W.)</aff>
              <aff id="af3-biomedicines-10-00138"><label>3</label>National Center for Biomedical Research in Space, University of Zurich, Innovation Cluster Space and Aviation (UZH Space Hub), 8600 Dübendorf, Switzerland</aff>
              <aff id="af4-biomedicines-10-00138"><label>4</label>Institute of Mechanical Engineering and Energy Technology, School of Engineering and Architecture, Lucerne University of Applied Sciences and Arts, 6048 Horw, Switzerland; <email>david.schiffmann@hslu.ch</email> (D.S.); <email>simon.maranda@hslu.ch</email> (S.M.); <email>silvan.vonarx@hslu.ch</email> (S.v.A.); <email>sebastian.ammann@hslu.ch</email> (S.A.)</aff>
              <aff id="af5-biomedicines-10-00138"><label>5</label>Institute of Electrical Engineering, School of Engineering and Architecture, Lucerne University of Applied Sciences and Arts, 6048 Horw, Switzerland; <email>raphael.kummer@hslu.ch</email> (R.K.); <email>christoph.zumbuehl@hslu.ch</email> (C.Z.)</aff>
              <aff id="af6-biomedicines-10-00138"><label>6</label>Buchmann Institute for Molecular Life Sciences (BMLS), Johann Wolfgang Goethe Universität, 60438 Frankfurt am Main, Germany; <email>frederic.strobl@physikalischebiologie.de</email> (F.S.); <email>berkane@med.uni-frankfurt.de</email> (R.B.); <email>stolz@em.uni-frankfurt.de</email> (A.S.); <email>ernst.stelzer@physikalischebiologie.de</email> (E.H.K.S.)</aff>
              <aff id="af7-biomedicines-10-00138"><label>7</label>Institute of Biochemistry 2, Johann Wolfgang Goethe Universität, 60438 Frankfurt am Main, Germany</aff>
              <author-notes>
                <corresp id="c1-biomedicines-10-00138"><label>*</label>Correspondence: <email>schleiff@bio.uni-frankfurt.de</email> (E.S.); <email>boehmer@bio.uni-frankfurt.de</email> (M.B.); Tel.: +49-69-798-29287 (E.S.); +49-69-798-29296 (M.B.)</corresp>
                <fn id="fn1-biomedicines-10-00138">
                  <label>†</label>
                  <p>These authors contributed equally to this work.</p>
                </fn>
              </author-notes>
              <pub-date pub-type="epub">
                <day>08</day>
                <month>1</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="collection">
                <month>1</month>
                <year>2022</year>
              </pub-date>
              <volume>10</volume>
              <issue>1</issue>
              <elocation-id>138</elocation-id>
              <history>
                <date date-type="received">
                  <day>23</day>
                  <month>12</month>
                  <year>2021</year>
                </date>
                <date date-type="accepted">
                  <day>05</day>
                  <month>1</month>
                  <year>2022</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© 2022 by the authors.</copyright-statement>
                <copyright-year>2022</copyright-year>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
                </license>
              </permissions>
              <abstract>
                <p>Calcium (Ca<sup>2+</sup>) elevation is an essential secondary messenger in many cellular processes, including disease progression and adaptation to external stimuli, e.g., gravitational load. Therefore, mapping and quantifying Ca<sup>2+</sup> signaling with a high spatiotemporal resolution is a key challenge. However, particularly on microgravity platforms, experiment time is limited, allowing only a small number of replicates. Furthermore, experiment hardware is exposed to changes in gravity levels, causing experimental artifacts unless appropriately controlled. We introduce a new experimental setup based on the fluorescent Ca<sup>2+</sup> reporter CaMPARI2, onboard LED arrays, and subsequent microscopic analysis on the ground. This setup allows for higher throughput and accuracy due to its retrograde nature. The excellent performance of CaMPARI2 was demonstrated with human chondrocytes during the 75th ESA parabolic flight campaign. CaMPARI2 revealed a strong Ca<sup>2+</sup> response triggered by histamine but was not affected by the alternating gravitational load of a parabolic flight.</p>
              </abstract>
              <kwd-group>
                <kwd>CaMPARI</kwd>
                <kwd>articular chondrocytes</kwd>
                <kwd>cytosolic free calcium</kwd>
                <kwd>gravity</kwd>
                <kwd>parabolic flight</kwd>
                <kwd>high throughput screening</kwd>
              </kwd-group>
            </article-meta>
          </front>
          <body>
            <sec sec-type="intro" id="sec1-biomedicines-10-00138">
              <title>1. Introduction</title>
              <p>Calcium (Ca<sup>2+</sup>) is a fundamental secondary messenger in all eukaryotic cells. Ca<sup>2+</sup> signaling components integrate chemical and physical stimuli to drive developmental and physiological responses. Among these processes are Ca<sup>2+</sup>-dependent neurotransmitter release, muscle contraction, or the biological and biochemical processes downstream of membrane receptors, as in the IP3 pathways, which play a role in regulating cell division [<xref rid="B1-biomedicines-10-00138" ref-type="bibr">1</xref>,<xref rid="B2-biomedicines-10-00138" ref-type="bibr">2</xref>,<xref rid="B3-biomedicines-10-00138" ref-type="bibr">3</xref>]. Ca<sup>2+</sup> signals vary in their amplitude, temporal and spatial properties, and site of Ca<sup>2+</sup> entry [<xref rid="B1-biomedicines-10-00138" ref-type="bibr">1</xref>]. Since increased cytosolic Ca<sup>2+</sup> concentrations can cause cell distress or even cell death [<xref rid="B2-biomedicines-10-00138" ref-type="bibr">2</xref>], maintaining Ca<sup>2+</sup> homeostasis is essential for living cells. Ca<sup>2+</sup>-transporters such as Ca<sup>2+</sup>-ATPases ensure a stable cytosolic Ca<sup>2+</sup> concentration by pumping Ca<sup>2+</sup> ions into the extracellular space or intracellular stores, mainly the endoplasmic reticulum (ER), from where they can be released into the cytosol upon signal activation [<xref rid="B3-biomedicines-10-00138" ref-type="bibr">3</xref>]. </p>
              <p>Since dysregulation of Ca<sup>2+</sup> homeostasis is related to many diseases, including skeletal muscle diseases, Alzheimer’s disease, and osteoporosis [<xref rid="B4-biomedicines-10-00138" ref-type="bibr">4</xref>,<xref rid="B5-biomedicines-10-00138" ref-type="bibr">5</xref>,<xref rid="B6-biomedicines-10-00138" ref-type="bibr">6</xref>], a more profound understanding of the involvement of Ca<sup>2+</sup> in these pathways could further medical drug development.</p>
              <sec id="sec1dot1-biomedicines-10-00138">
                <title>1.1. Genetically Encoded Ca<sup>2+</sup> Indicators</title>
                <p>A toolset of Ca<sup>2+</sup>-reactive dyes and genetically encoded Ca<sup>2+</sup> indicators are available to study spatial and temporal properties of Ca<sup>2+</sup> signaling in vivo [<xref rid="B7-biomedicines-10-00138" ref-type="bibr">7</xref>]. One example among the fluorescent dyes is Fura-2, containing an 8-coordinate tetracarboxylic chelating site and stilbene chromophores. Upon Ca<sup>2+</sup>-binding, conformational changes increase the fluorescence intensity up to 30-fold [<xref rid="B8-biomedicines-10-00138" ref-type="bibr">8</xref>]. In addition, genetically encoded Ca<sup>2+</sup> indicators (GECIs) have been generated to measure intracellular Ca<sup>2+</sup> concentrations in a non-invasive fashion. GECIs are engineered fluorescent proteins that change conformation in response to the cytosolic Ca<sup>2+</sup> concentration [<xref rid="B9-biomedicines-10-00138" ref-type="bibr">9</xref>]. </p>
                <p>GECIs such as the fluorescence protein-based Ca<sup>2+</sup> indicators R-GECO and Cameleon provide a much stronger quantum yield and increased resolution for live-cell imaging [<xref rid="B10-biomedicines-10-00138" ref-type="bibr">10</xref>,<xref rid="B11-biomedicines-10-00138" ref-type="bibr">11</xref>]. R-GECO (red fluorescent genetically encoded Ca<sup>2+</sup> indicator for optical imaging) is an intensiometric Ca<sup>2+</sup> sensor whose fluorescence intensity increases in response to rising cytosolic Ca<sup>2+</sup> concentrations. These GCaMP-class Ca<sup>2+</sup> imaging proteins consist of a green fluorescent protein (GFP)- or red fluorescent protein (RFP)-derived fluorophore fused to calmodulin (CaM) and an M13 peptide. When Ca<sup>2+</sup> binds to calmodulin, the two GFP or RFP halves come together to form a functional fluorescent protein [<xref rid="B10-biomedicines-10-00138" ref-type="bibr">10</xref>,<xref rid="B11-biomedicines-10-00138" ref-type="bibr">11</xref>].</p>
                <p>The Cameleon-type Ca<sup>2+</sup> reporters are ratiometric FRET (Förster resonance energy transfer) based indicators. An enhanced cyan fluorescent protein (ECFP) serves as the FRET donor, whereas a yellow fluorescence protein (YFP) works as a FRET acceptor [<xref rid="B12-biomedicines-10-00138" ref-type="bibr">12</xref>]. With increasing Ca<sup>2+</sup> concentrations, increased amounts of energy are transferred to the acceptor protein [<xref rid="B12-biomedicines-10-00138" ref-type="bibr">12</xref>]. </p>
                <p>However, in both systems, the changes in fluorescence intensity or FRET are reversible, making it necessary to image samples in real-time to observe changes in cytosolic Ca<sup>2+</sup> concentrations. Therefore, these spatial and temporal dependencies of observation and treatment limit the number of samples analyzed drastically.</p>
              </sec>
              <sec id="sec1dot2-biomedicines-10-00138">
                <title>1.2. CaMPARI</title>
                <p>CaMPARI (calcium-modulated photoactivatable ratiometric integrator) is based on the fluorescent protein mEos that irreversibly converts from green to red emission when illuminated with near UV light at 405 nm [<xref rid="B13-biomedicines-10-00138" ref-type="bibr">13</xref>]. In CaMPARI, a circular permutated Eos (cpEos) is attached to CaM and an M13 peptide. In contrast to mEos alone, photoconversion in CaMPARI is calcium-dependent, and efficient and irreversible green-to-red conversion only occurs when elevated intracellular Ca<sup>2+</sup> and 405 nm illumination coincide [<xref rid="B13-biomedicines-10-00138" ref-type="bibr">13</xref>]. The latest iteration, CaMPARI2, was designed with a two-fold increase in red fluorescence intensity, a higher Ca<sup>2+</sup>-binding rate, and a significantly increased red-to-green fluorescence ratio than the original CaMPARI [<xref rid="B14-biomedicines-10-00138" ref-type="bibr">14</xref>]. In addition, several variants were developed with distinct affinities to cytosolic Ca<sup>2+</sup>. </p>
                <p>With CaMPARI, a decoupling of treatment and analysis is possible. The green-to-red conversion is caused by a covalent, and therefore stable fluorophore modification. The red-to-green ratio thus offers a snapshot of intracellular Ca<sup>2+</sup> concentrations at the time of photoconversion and is only affected by the new synthesis of CaMPARI protein in its initial green form and the degradation of red CaMPARI. Considering these factors, the signal can remain constant for from hours to several weeks [<xref rid="B15-biomedicines-10-00138" ref-type="bibr">15</xref>]. Furthermore, the simplicity of CaMPARI photoconversion at a distinct time point during an experiment enables the simultaneous investigation of Ca<sup>2+</sup> concentrations in many samples. </p>
                <p>This decoupling is advantageous, especially for rather unconventional experimental conditions, where it is challenging to treat and measure cell culture simultaneously. One example of these experimental conditions are parabolic flights: The mechanical load on microgravity platforms makes conventional electrophysiological measurements, requiring precise micromanipulation, very challenging [<xref rid="B16-biomedicines-10-00138" ref-type="bibr">16</xref>]. Therefore, in recent years, non-invasive optical instruments such as plate readers [<xref rid="B17-biomedicines-10-00138" ref-type="bibr">17</xref>] or the FLUMIAS microscopes [<xref rid="B18-biomedicines-10-00138" ref-type="bibr">18</xref>,<xref rid="B19-biomedicines-10-00138" ref-type="bibr">19</xref>,<xref rid="B20-biomedicines-10-00138" ref-type="bibr">20</xref>] have been used. For example, cells were stained with fluorescent dyes, such as Fura-2 or Fura-3, to measure changes in Ca<sup>2+</sup> concentrations [<xref rid="B17-biomedicines-10-00138" ref-type="bibr">17</xref>,<xref rid="B21-biomedicines-10-00138" ref-type="bibr">21</xref>]. However, when using a plate reader or a microscope during a parabolic flight, the experiment hardware is exposed to accelerations, resulting in experimental artifacts if not adequately controlled [<xref rid="B22-biomedicines-10-00138" ref-type="bibr">22</xref>]. </p>
                <p>In this work, we present a much more robust approach: we use multiple 405 nm LED arrays to convert CaMPARI2 from the green to the red fluorescent state in a large number of 96-well plates. As a marker of cytosolic Ca<sup>2+</sup> concentration, the green-to-red conversion was measured after the flight using a ground-based Sartorius’ IncuCyte S3 high-throughput fluorescence microscope that allowed large-scale imaging of up to six 96-well plates in parallel. We used the human chondrocyte cell culture C28/I2 as a model for the experiments presented here. </p>
              </sec>
              <sec id="sec1dot3-biomedicines-10-00138">
                <title>1.3. Chondrocytes and Histamine</title>
                <p>Chondrocytes are the only living cells found in cartilage. They maintain healthy articular joints, e.g., by synthesizing and secreting the extracellular matrix and lubricants like hyaluronan and lubricin [<xref rid="B23-biomedicines-10-00138" ref-type="bibr">23</xref>]. However, they are also involved in developing rheumatoid- and osteoarthritis [<xref rid="B24-biomedicines-10-00138" ref-type="bibr">24</xref>,<xref rid="B25-biomedicines-10-00138" ref-type="bibr">25</xref>,<xref rid="B26-biomedicines-10-00138" ref-type="bibr">26</xref>,<xref rid="B27-biomedicines-10-00138" ref-type="bibr">27</xref>,<xref rid="B28-biomedicines-10-00138" ref-type="bibr">28</xref>,<xref rid="B29-biomedicines-10-00138" ref-type="bibr">29</xref>]. Both forms of arthritis are characterized by degeneration and loss of articular cartilage. However, in osteoarthritis, the cause is mechanical wear on the joints, while rheumatoid arthritis is an autoimmune disease in which the body’s immune system attacks the body’s joints. </p>
                <p>Immunohistochemical staining identified an enhanced abundance of histamine H1 and H2 receptors and the histamine-producing enzyme histidine decarboxylase in a variable proportion of human articular chondrocytes in osteoarthritis cartilage specimens. Furthermore, histamine was found with concentrations of up to 210 nM in synovial fluid in patients with rheumatoid arthritis [<xref rid="B30-biomedicines-10-00138" ref-type="bibr">30</xref>]. Histamine has a primary role in allergic and inflammatory reactions, but it also stimulates chondrocyte proliferation [<xref rid="B31-biomedicines-10-00138" ref-type="bibr">31</xref>,<xref rid="B32-biomedicines-10-00138" ref-type="bibr">32</xref>]. Taken together, this strongly suggests that histamine and histamine receptor expression in osteoarthritis cartilage is potentially a pivotal contributor to the aberrant hyperactive phenotype of osteoarthritis chondrocytes, including their ability to express pro-inflammatory cytokines and cartilage-degrading enzymes [<xref rid="B32-biomedicines-10-00138" ref-type="bibr">32</xref>,<xref rid="B33-biomedicines-10-00138" ref-type="bibr">33</xref>,<xref rid="B34-biomedicines-10-00138" ref-type="bibr">34</xref>].</p>
                <p>The binding of histamine to histamine receptors triggers an influx of Ca<sup>2+</sup> into chondrocytes. However, the precise regulation of Ca<sup>2+</sup> homeostasis in these cells is an essential factor for standard matrix metabolic and secretory functions [<xref rid="B35-biomedicines-10-00138" ref-type="bibr">35</xref>,<xref rid="B36-biomedicines-10-00138" ref-type="bibr">36</xref>]. A disturbance of Ca<sup>2+</sup> homeostasis can contribute to chronic articular joint disease, such as arthritis and related inflammation [<xref rid="B24-biomedicines-10-00138" ref-type="bibr">24</xref>,<xref rid="B27-biomedicines-10-00138" ref-type="bibr">27</xref>,<xref rid="B28-biomedicines-10-00138" ref-type="bibr">28</xref>,<xref rid="B29-biomedicines-10-00138" ref-type="bibr">29</xref>,<xref rid="B37-biomedicines-10-00138" ref-type="bibr">37</xref>]. The role of Ca<sup>2+</sup> signaling in chondrocytes has recently been reviewed in detail [<xref rid="B38-biomedicines-10-00138" ref-type="bibr">38</xref>]. In this work, we used treatment with histamine as a positive control stimulus to trigger intracellular Ca<sup>2+</sup> elevation. </p>
                <p>In addition to biochemical stimuli, physical stimulation of chondrocytes leads to Ca<sup>2+</sup> elevations in the cytosol [<xref rid="B39-biomedicines-10-00138" ref-type="bibr">39</xref>]. For example, exposure of isolated chondrocytes to osmotic challenges [<xref rid="B39-biomedicines-10-00138" ref-type="bibr">39</xref>,<xref rid="B40-biomedicines-10-00138" ref-type="bibr">40</xref>,<xref rid="B41-biomedicines-10-00138" ref-type="bibr">41</xref>,<xref rid="B42-biomedicines-10-00138" ref-type="bibr">42</xref>,<xref rid="B43-biomedicines-10-00138" ref-type="bibr">43</xref>,<xref rid="B44-biomedicines-10-00138" ref-type="bibr">44</xref>,<xref rid="B45-biomedicines-10-00138" ref-type="bibr">45</xref>,<xref rid="B46-biomedicines-10-00138" ref-type="bibr">46</xref>], fluid flow [<xref rid="B47-biomedicines-10-00138" ref-type="bibr">47</xref>], compression [<xref rid="B48-biomedicines-10-00138" ref-type="bibr">48</xref>], deformation [<xref rid="B49-biomedicines-10-00138" ref-type="bibr">49</xref>,<xref rid="B50-biomedicines-10-00138" ref-type="bibr">50</xref>], and aspiration [<xref rid="B51-biomedicines-10-00138" ref-type="bibr">51</xref>] have reportedly triggered increased cytosolic free calcium. Furthermore, mechanical stimulation and subsequent Ca<sup>2+</sup> elevations increase the synthesis of extracellular matrix (ECM) proteins [<xref rid="B52-biomedicines-10-00138" ref-type="bibr">52</xref>]. Therefore, chondrocytes have been used as model systems to study changes in intracellular Ca<sup>2+</sup> concentrations to understand mechanotransduction pathways [<xref rid="B16-biomedicines-10-00138" ref-type="bibr">16</xref>].</p>
                <p>With an absence of mechanical load on the articular matrix, for example, in microgravity during spaceflights, the maintenance of the extracellular matrix is reduced. This effect is under investigation for manned space travel since it leads to osteoarthritis, dramatic degeneration of cartilage, and bone mass degradation [<xref rid="B53-biomedicines-10-00138" ref-type="bibr">53</xref>]. A healthy cartilaginous matrix is necessary to improve astronauts’ health in the future, especially regarding potential long-term space travel missions. Therefore, further understanding of the molecular involvement of Ca<sup>2+</sup> in these processes is required.</p>
                <p>In intact cartilage, the onset of a Ca<sup>2+</sup> elevation in response to physical stimuli is observable within 6–12 s [<xref rid="B54-biomedicines-10-00138" ref-type="bibr">54</xref>], i.e., within the time frame of a single parabola during a parabolic flight. In this study, we implemented CaMPARI2, a genetically encoded Ca<sup>2+</sup> indicator, and designed photoconversion hardware to measure changes in intracellular Ca<sup>2+</sup> concentrations in chondrocytes during the different gravity phases of a parabolic flight and in response to histamine.</p>
              </sec>
            </sec>
            <sec id="sec2-biomedicines-10-00138">
              <title>2. Materials and Methods</title>
              <sec id="sec2dot1-biomedicines-10-00138">
                <title>2.1. Vector Construction</title>
                <p>The coding sequences of the five CaMPARI2 variants wt (Addgene #101060), F391W (Addgene #101061), L398T (Addgene #101064), F391WG395D (Addgene #101063), H396K (Addgene #101062) were amplified from the original pAAV vectors via PCR using primer pair CaMPARI2_attB1_KZ 5′-GGGGACAAGTTTGTACAAAAAAGCAGGCTGCCACCATGCTGCAGAACGAGCTTGC-3′ and CaMPARI2_attB2 5′-GGGGACCACTTTGTAC-AAGAAAGCTGGGTTTTATGAGCTCAGCCGACCTA-3′. PCR products were cloned into pDONR221 (Invitrogen) via BP reaction. The CaMPARI2 reporters were then transferred into the destination vector pMAX-DEST (Addgene #37631), using the Gateway<sup>®</sup> LR Clonase<sup>®</sup> II enzyme mix. The resulting pMAX-plasmids contained a CMV-promotor for eukaryotic cells, a Kozak sequence, a nuclear export signal, a His<sub>6</sub>-epitope tag, and a terminating SV40 polyA-tag.</p>
              </sec>
              <sec id="sec2dot2-biomedicines-10-00138">
                <title>2.2. Cell Culture and Treatment</title>
                <p>The C28/I2 human chondrocyte cell line [<xref rid="B55-biomedicines-10-00138" ref-type="bibr">55</xref>,<xref rid="B56-biomedicines-10-00138" ref-type="bibr">56</xref>] as purchased from Merck (Schaffhausen, Switzerland) and maintained in T75 flasks containing Dulbecco’s Modified Eagle’s Medium (DMEM, w: 1.0 g/L Glucose, w: L-Glutamine, w: 25 mM HEPES, w: Sodium pyruvate, w: 3.7 g/L NaHCO<sub>3</sub>, PAN Biotech, Aidenbach, Germany) supplemented with 10% fetal bovine serum (FBS, Cytiva, Marlborough, MA, USA) and 1% PenStrep in a 37 °C incubator in a 5% CO<sub>2</sub> atmosphere. Cells were subcultured in a 1:5 ratio (1 × 10<sup>6</sup> cells/T75 flask) when they reached 80–90% confluence. The cells were harvested with Trypsin and washed with PBS. </p>
                <p>For treatments, cells were plated in 96-well plates (7000 cells per well) and cultured at 37 °C for 72 h. Then cells were exposed to a parabolic flight for the indicated times. Histamine-treated cells were exposed to 100 µM histamine for 15 s immediately after the parabolic flight.</p>
              </sec>
              <sec id="sec2dot3-biomedicines-10-00138">
                <title>2.3. Chondrocyte Transfection</title>
                <p>C28/I2 chondrocytes were transfected using Lipofectamine 3000. A total of 7000 cells were seeded per well into eight 96-well-plates (µCLEAR<sup>®</sup> BLACK 655090, Greiner Bio-One, Frickenhausen, Germany) for every flight day, 24 plates in total. After 24 h in a 5% CO<sub>2</sub> atmosphere at 37 °C, each well was treated according to the manufacturer’s protocol with 200 ng of DNA, 0.4 µL of P3000 reagent, and 0.6 µL of Lipofectamine 3000 reagent. The transformed vectors were the three constructs pmaxGFP (Lonza), pMAX-DEST CaMPARI2 [K<sub>D</sub> = 199.2] and pMAX-DEST CaMPARI2-F391W [K<sub>D</sub> = 109.7]. Cells in each well were incubated with 200 µL DMEM medium and the transfection reagents for 44 h before the flight day.</p>
              </sec>
              <sec id="sec2dot4-biomedicines-10-00138">
                <title>2.4. Parabolic Flight Experimental Design</title>
                <p>Parabolic flights are among the most used ground-based platforms in gravitational research that expose samples to real microgravity [<xref rid="B57-biomedicines-10-00138" ref-type="bibr">57</xref>]. The experimental design for the parabolic flight experiments consisted of three replicate flight days, all flown during the 75th ESA parabolic flight campaign in Bordeaux, France. Each flight day comprised 31 consecutive parabolas. A single parabola comprises 5 flight phases (<xref rid="biomedicines-10-00138-f001" ref-type="fig">Figure 1</xref>); the Pre-Parabola and Post-Parabola phases just before and after the parabola at 1 g, the Pull-Up and Pull-Out phases at the beginning and end of the parabola at around 1.8 g each, and the Zero-G phase at around 10<sup>−5</sup> g. Each parabola offers about 20 s of hypergravity (Pull-Up phase), followed by ca. 22 s of microgravity (Zero-G phase), and concluded by another 20 s of hypergravity (Pull-Out phase) (<xref rid="biomedicines-10-00138-f001" ref-type="fig">Figure 1</xref>). The 96-well plates with chondrocytes were kept inside the flight hardware at 37 °C in an ambient atmosphere and were illuminated by LED light for photoconversion during parabolas 0, 10, 20, and 30.</p>
              </sec>
              <sec id="sec2dot5-biomedicines-10-00138">
                <title>2.5. Parabolic Flight Hardware</title>
                <p>Novel custom-made hardware consisting of four identical functional units was developed to guarantee optimal cell culture condition and precise synchronization of the photoconversion with the parabolic maneuvers (<xref rid="biomedicines-10-00138-f002" ref-type="fig">Figure 2</xref>). Two 96-well plates were placed in each unit. Each well was irradiated using an LED array placed below the 96-well plate at the indicated time point. A black spacer between the individual LEDs of the LED array and the usage of black 96-well plates ensured homogeneous illumination and prevented cross irradiation of neighboring wells. The LEDs (ATDS3534UV405B, Kingbright, New Taipei City, Taiwan) had a peak emission at 405 ± 5 nm and ca. 1.1 W radiant flux. However, the LEDs’ power dissipation of ca. 2.8 W (per LED) required thermal management to prevent overheating of the cells (described below). </p>
                <p>The functional unit structure (<xref rid="biomedicines-10-00138-f002" ref-type="fig">Figure 2</xref>) was mainly manufactured from 3D-printed acrylonitrile butadiene styrene (ABS) and was tailored to the 96-well plate to avoid undesired plate movement during the flight. The sterile 96-well plates were sealed before integration, placed in the hardware, and secured with a lid and elastic spring elements. The LEDs were mounted on a single custom-made printed circuit board (PCB) with an aluminum core, integrated into the 3D-printed housing. A second custom-made PCB featured a microcontroller (tinyK22 designed by the Lucerne School of Engineering and Architecture, Horw, Switzerland), and interfaced with peripheral devices such as LEDs and sensors. The microcontroller controlled all components in the unit, provided a serial communication interface to an external board computer (laptop), and logged various housekeeping data, including acceleration, temperature, air pressure, supply voltage, and power consumption. Just below the PCB with the LEDs, a thermal buffer was integrated. Finally, the units were placed in air-tight aluminum containers for safety reasons to avoid environmental contamination in case of media leakage.</p>
                <p>After the units were prepared and closed in the laboratory, they were mounted into a flight rack screwed to the aircraft floor. The air-tight aluminum containers and the flight rack were reused from a previous parabolic flight campaign [<xref rid="B58-biomedicines-10-00138" ref-type="bibr">58</xref>]. In brief, the rack was built according to the requirements of Novespace (Bordeaux, France), and could provide space for up to 12 units. The units were packed in polyurethane foam to reduce mechanical vibration and ensure thermal insulation. Custom-made software was executed from a laptop, which controlled all units and measured acceleration during the flight to trigger the photoconversion synchronously with the parabolic maneuver. </p>
              </sec>
              <sec id="sec2dot6-biomedicines-10-00138">
                <title>2.6. Thermal Management</title>
                <p>A heating element was integrated into the spacer between the 96-well plates and the LEDs to stabilize the samples’ temperature at 37 °C (<xref rid="biomedicines-10-00138-f002" ref-type="fig">Figure 2</xref>). This was realized with a custom-made PCB manufactured on thermally well-conducting aluminum featuring a resistor array and a temperature sensor. Heating power was regulated by the microcontroller using the temperature sensors as feedback. The experiment had to be powered off during take-off and landing for safety reasons. Therefore, the units were packed in foam to guarantee sufficient thermal insulation during this period.</p>
                <p>Each LED dissipated around 2.8 W when illuminated. In our experiment, per treatment condition and parabola, 11 wells were illuminated in rapid succession for 8 s each. Per unit, four LEDs were illuminated in parallel at the same time. Therefore, per unit and parabola, the 44 LEDs generated ca. 986 J of heat energy within less than 2 min. However, the insulation around the units prevented the fast dissipation of this excessive heat to the aircraft’s cabin. Hence, a thermal buffer was placed below the LED array to prevent overheating the samples. The buffer consisted of paraffin wax (Eicosane; Merck, Schaffhausen, Switzerland), with a melting point at ca. 36 °C, enclosed in an aluminum casing. It stabilized the temperature two-fold. First, during take-off and landing, it helped slow down cooling in combination with the insulation. Second, the buffer absorbed the heat generated by the LEDs during illumination. For this reason, the LEDs were mounted on an aluminum PCB, and the buffer’s casing was also made of aluminum and was mounted in close contact with the LED’s PCB. This design ensured that the heat energy from the LEDs would be quickly conducted away and absorbed by the paraffin wax.</p>
              </sec>
              <sec id="sec2dot7-biomedicines-10-00138">
                <title>2.7. Before the Flight</title>
                <p>Four hours before the flight, chondrocytes were washed with 200 µL PBS. Then DMEM containing one of the drugs listed in <xref rid="biomedicines-10-00138-t001" ref-type="table">Table 1</xref> was added to each 96-well plate until a meniscus of liquid formed above each well (380–385 µL) to avoid all physical interference of air bubbles during the flight. To ensure the absence of air bubbles and prevent leakage during the flight, the plates were sealed with adhesive film (Greiner Bio-One™ EASYseal™, 676001) and placed inside the preheated hardware.</p>
              </sec>
              <sec id="sec2dot8-biomedicines-10-00138">
                <title>2.8. During the Flight</title>
                <p>During parabolas 0, 10, 20, and 30 of each of the three flights, individual wells were illuminated for 8 s with photoconversion light. First, one well transfected with turbo-GFP was illuminated, followed consecutively by ten wells of CaMPARI2 or CaMPARI2-F391W, respectively. During normal gravity, two wells were illuminated, followed by two wells during the Pull-Up phase, two wells during the Zero-G phase, two wells during the Pull-Out phase, and finished by two wells at normal gravity Post-Parabola (<xref rid="biomedicines-10-00138-f001" ref-type="fig">Figure 1</xref>).</p>
              </sec>
              <sec id="sec2dot9-biomedicines-10-00138">
                <title>2.9. After the Flight</title>
                <p>The seal’s adhesion was checked after the flight, and no air bubbles or leakages were detectable. For each parabola-set of cells, one well served as a positive control for photo conversion of CaMPARI2 and CaMPARI2-F391W with 100 µM histamine after the flight. The medium of these eight wells per plate was discarded directly after the flight, and DMEM cell culture medium containing 100 µM histamine was added to the wells. After 15 s, these wells were illuminated with the flight hardware for 8 s, and the wells were filled up with medium to 380 µL again. Subsequently, phase contrast and fluorescence images in the green and red channels were acquired. All plates were scanned on-site with an IncuCyte S3 microscope equipped with an IncuCyte Zoom 10 Plan Fluor objective (Sartorius, Göttingen, Germany). For each well, five non-overlapping regions were imaged.</p>
              </sec>
              <sec id="sec2dot10-biomedicines-10-00138">
                <title>2.10. Image Analysis and Statistics</title>
                <p>For the analysis of the images taken by the IncuCyte S3 microscope, the basic analyzer of the IncuCyte 2021A software (Sartorius, Göttingen, Germany) was used. The optimal settings were determined based on 50 individual representative images as a sample for the 11,520 total images the IncuCyte S3 microscope took during the campaign. To detect green and red fluorescent cells (CaMPARI green and CaMPARI red), the segmentation adjustment was set to 1.0, and Top-Hat segmentation edge sensitivity was set to −30. A cleanup filter for hole fill of the non-fluorescent nuclei with 200 µm<sup>2</sup> was applied, and an area filter of 150–5500 µm<sup>2</sup> led to the recognition of objects only in the specified size range. The cell radius for both green and red fluorescent objects was set to 25 µm. The threshold for green computational units (GCU) was set to 4, and for the weaker red fluorescent signal of CaMPARI2, the red computational unit threshold (RCU) was set to 0.3. Finally, four different analysis metrics were calculated to quantify photoconversion in the C28/I2 cells (<xref rid="biomedicines-10-00138-t002" ref-type="table">Table 2</xref>). </p>
                <p>These four analysis metrics were graphed and statistically evaluated using in-house R scripts. In addition, the quantitative image analysis metrics were matched with acceleration data, plate layouts, inhibitors, voltage supply, parabola numbers, temperatures, and measured acceleration. A repository with the R scripts (release 1.0) and the quantitative results from the IncuCyte 2021A software is available from GitHub (<uri xlink:href="https://github.com/ZeroG-lab/PFCaMPARI">https://github.com/ZeroG-lab/PFCaMPARI</uri>; accessed on 5 January 2022). Finally, statistical analyses were performed using ANOVA and Tukey post-test. </p>
              </sec>
            </sec>
            <sec sec-type="results" id="sec3-biomedicines-10-00138">
              <title>3. Results</title>
              <sec id="sec3dot1-biomedicines-10-00138">
                <title>3.1. Selection of CaMPARI2-Constructs</title>
                <p>Expression and photoconversion of five CaMPARI2 constructs (CaMPARI2-F391W, CaMPARI2, CaMPARI2-H396K, CaMPARI2-F391W-G395D, and CaMPARI2-L398T) were tested after transient transformation into C28/I2 human chondrocytes to select CaMPARI2 variants with adequate photoconversion rates in response to a positive stimulus. As a result, all five variants could be expressed, and photoconversion was detectable after a 15-s treatment with 100 µM histamine and 4 s of 405 nm photoconversion light (<xref rid="biomedicines-10-00138-f003" ref-type="fig">Figure 3</xref>). Notably, the fluorescence intensity of the CaMPARI2-H396K variant was overall reduced, and the photoconversion rate of this variant was lower than expected based on the previously determined in vitro K<sub>D</sub>-values [<xref rid="B14-biomedicines-10-00138" ref-type="bibr">14</xref>].</p>
                <p>CaMPARI2-F391W and CaMPARI2, on the other hand, showed high photoconversion rates with 65% and 55%, respectively, without reaching saturation. Moreover, in non-elicited cells, these variants displayed 13% and 2% photoconversion rates, respectively (Pre-Parabola condition, <xref rid="biomedicines-10-00138-f004" ref-type="fig">Figure 4</xref>), indicating an already high sensitivity to basal calcium. These results are consistent with published basal cytosolic Ca<sup>2+</sup> concentration in mammalian chondrocytes between 100 and 200 nM [<xref rid="B67-biomedicines-10-00138" ref-type="bibr">67</xref>]. Furthermore, with K<sub>D</sub> values of 199.2 nM for CaMPARI2 and 109.7 nM for CaMPARI2-F391W, the Ca<sup>2+</sup> affinities of both variants are also higher than those of Fura-2-AM at 285 nM [<xref rid="B68-biomedicines-10-00138" ref-type="bibr">68</xref>]. </p>
                <p>Next, C28/I2 cells were transfected with the CaMPARI2-F391W-G395D construct to determine the optimal illumination duration. This construct was used due to its low Ca<sup>2+</sup>-affinity, which allowed for longer illumination times and made an analysis of a photoconversion time course up to 32 s possible (<xref rid="biomedicines-10-00138-f003" ref-type="fig">Figure 3</xref>). </p>
                <p>CaMPARI2-F391W-G395D expressed in the C28/I2 human chondrocyte cell underwent visible photoconversion already after 1 s of illumination. After that short time, about 50% of the maximum possible red fluorescence after illumination was reached. However, the transfection of cells with Lipofectamine 3000 also led to dead cell artifacts when measuring red fluorescence due to the transfection agent’s cytotoxicity (<xref rid="biomedicines-10-00138-f001" ref-type="fig">Figure 1</xref>A, cells without histamine treatment after 16-sec illumination). Therefore, the photoconversion time was set to 8 s for the parabolic flight experiments to gain an optimal signal-to-noise ratio. Furthermore, using the variants CaMPARI2 and CaMPARI2-F391W, which have the highest affinity to Ca<sup>2+</sup>, for the parabolic flight will further increase the number of converted cells and improve the signal-to-noise ratio.</p>
              </sec>
              <sec id="sec3dot2-biomedicines-10-00138">
                <title>3.2. Gravi-Elicited Ca<sup>2+</sup> Elevation Changes during a Parabolic Flight</title>
                <p>To investigate gravity-elicited changes in cytosolic Ca<sup>2+</sup>-concentrations in chondrocytes during the 75th ESA parabolic flight campaign, novel hardware was designed to perform the photoconversion of CaMPARI2 during the flight (Materials and Methods, <xref rid="sec2dot5-biomedicines-10-00138" ref-type="sec">Section 2.5</xref>). Before each flight, the functional units were preheated to 37 °C overnight. In the morning, 2–3 h before take-off, the 96-well plates containing the C28/I2 human chondrocytes transfected with CaMPARI2-F391W and CaMPARI2 were treated with inhibitors (s. <xref rid="biomedicines-10-00138-t001" ref-type="table">Table 1</xref>) and transferred into the functional units. Those were then installed and connected to the flight rack (<xref rid="biomedicines-10-00138-f002" ref-type="fig">Figure 2</xref>).</p>
                <p>One hour after take-off, for approximately 1.5 h, the cells were exposed to a total of 31 parabolas, each consisting of three phases, a 20 s hypergravity-phase (Pull-Up) at ca. 1.5–1.8 g, a 22 s microgravity-phase (Zero-G), and another 20 s hypergravity-phase (Pull-Out) (<xref rid="biomedicines-10-00138-f001" ref-type="fig">Figure 1</xref>). During parabolas 0, 10, 20, and 30, individual wells were illuminated for 8 s, each, with photoconversion light to record a time course of Ca<sup>2+</sup> elevation changes during the different g-levels. </p>
                <p>Pre-Parabola, two wells of cells expressing GFP, followed by two wells each of cells expressing CaMPARI2 and CaMPARI2-F391W, were sequentially illuminated. Subsequently, two wells of each CaMPARI2 construct were illuminated during the Pull-Up phase, two wells during the Zero-G phase, two wells during the Pull-Out phase, and finished by two wells at normal gravity Post-Parabola (<xref rid="biomedicines-10-00138-f001" ref-type="fig">Figure 1</xref>). Finally, one hour after the last parabola, the plane returned to Bordeaux (France), and the cells were immediately transported to the laboratory.</p>
                <p>The hardware performed as intended. The brief temperature overshot during illumination, measured at the heating elements in contact with the samples, was ≤0.5 °C in all units and flights. </p>
                <p>As a positive control for cell fitness and the general ability of CaMPARI2 and CaMPARI2-F391W for photoconversion, one well per parabola and construct (8 wells per plate in total) were treated with 100 µM histamine for 15 s and illuminated for 8 s by 405 nm photoconversion light (<xref rid="biomedicines-10-00138-f003" ref-type="fig">Figure 3</xref>).</p>
                <p>The IncuCyte S3 microscope then imaged all eight 96-well plates. After applying the mask created in the IncuCyte 2021A software (Materials and Methods, <xref rid="sec2dot7-biomedicines-10-00138" ref-type="sec">Section 2.7</xref>), photoconversion of CaMPARI2 and CaMPARI2-F391W in each well was quantified (<xref rid="biomedicines-10-00138-f005" ref-type="fig">Figure 5</xref>). </p>
                <p>The fluorescence intensity-based metrics were significantly less reliable than the conversion rate due to microscopy artifacts, including dead cells and other debris with strong red autofluorescence (<xref rid="app1-biomedicines-10-00138" ref-type="app">Supplemental Figure S1</xref>). Nevertheless, despite slight variations in the resulting analysis between the four metrics, the inhibitors showed similar effects regarding the conversion of the different CaMPARI2 constructs.</p>
              </sec>
              <sec id="sec3dot3-biomedicines-10-00138">
                <title>3.3. Construct and Flight-Specific Conversion Rate</title>
                <p>When comparing the two constructs used for the transfection of C28/I2 cells, the differences between CaMPARI2 and CaMPARI2-F391W are noticeable (<xref rid="biomedicines-10-00138-f004" ref-type="fig">Figure 4</xref>). During the parabolas, the conversion rate of CaMPARI2 transfected cells is very low. Only 1–3% of cells show the conversion to red. The histamine control shows a conversion rate of 40%. CaMPARI2-F391W, on the other hand, shows a basal conversion rate of 10 to 15% during the different flight maneuvers. The histamine-treated cells transfected with CaMPARI2-F391W show a 45 to 60% conversion rate. C28/I2 cells were also transfected with GFP as a negative control for photo conversion since GFP cannot convert to red fluorescence under the illumination of 405 nm light. Both CaMPARI2 constructs indicate no significant change in cytosolic Ca<sup>2+</sup> concentration during different parabolic flight phases. When taking a closer look at the conversion rate of 96-well plates with the different treatments of cells transfected with CaMPARI2-F391W during each flight phase (<xref rid="biomedicines-10-00138-f006" ref-type="fig">Figure 6</xref>), there is also no significant increase or decrease of cytosolic Ca<sup>2+</sup> compared to the Pre-Parabola phase visible. Similar results were visible for the CaMPARI2 construct, albeit the base conversion rate was much lower, corresponding to the results described in <xref rid="biomedicines-10-00138-f004" ref-type="fig">Figure 4</xref> (<xref rid="app1-biomedicines-10-00138" ref-type="app">Supplemental Figure S2</xref>). However, slight deviations can be detected by comparing the overall base conversion of differently treated 96-well plates. Compared to the untreated 96-well plate, the plates treated with GSK2193874 and Thapsigargin 5 h before the parabolas contained 5–10% more converted cells during all phases of the parabolic flight.</p>
              </sec>
              <sec id="sec3dot4-biomedicines-10-00138">
                <title>3.4. Inhibitor Specific Conversion Rate</title>
                <p>To compare the different conditions of the eight 96-well plates used for the parabolic flight campaign, the after-flight positive control of CaMPARI2-F391W with histamine was analyzed (<xref rid="biomedicines-10-00138-f007" ref-type="fig">Figure 7</xref>). The cells were treated with 100 µM histamine directly after each flight. After 15 s of incubation, the cells were illuminated for 8 s with 405 nm photoconversion light. The conversion rate of the Pre-Parabola phase of each inhibitor was subtracted from the conversion rates to account for differences in photoconversion by basal Ca<sup>2+</sup> levels (compare <xref rid="biomedicines-10-00138-f006" ref-type="fig">Figure 6</xref> and <xref rid="biomedicines-10-00138-f007" ref-type="fig">Figure 7</xref>). Untreated samples and samples with DMSO-control, gadolinium chloride, and ruthenium red had comparable conversion rates. GSK2193874 reduced the conversion rate of C28/I2 cells by around 50% compared to untreated cells. Thapsigargin, flunarizine, and BAPTA completely blocked photoconversion of CaMPARI2-F391W.</p>
              </sec>
              <sec id="sec3dot5-biomedicines-10-00138">
                <title>3.5. Z’-Factor Analysis</title>
                <p>The Z’ factor is widely used to measure the suitability of an assay for high-throughput analyses [<xref rid="B69-biomedicines-10-00138" ref-type="bibr">69</xref>], and was calculated here to determine the efficiency of CaMPARI2-F391W in high throughput Ca<sup>2+</sup> concentration measurements, particularly in the context of inhibitor screening. C28/I2 cells from all four parabolas of each flight, treated with 100 µM histamine alone, were compared to those cells pretreated with 10 µM BAPTA-AM and subsequently with 100 µM histamine. Z’-factors of 0.72, 0.49, and 0.75 were calculated, respectively (<xref rid="biomedicines-10-00138-f008" ref-type="fig">Figure 8</xref>, <xref rid="app1-biomedicines-10-00138" ref-type="app">Supplementary Figure S3</xref>), which indicates an excellent separation of positive and negative control samples. The Z’-factors were calculated for each flight separately since, for every flight, a different batch of cells was used and was transfected on different days, making it a different assay.</p>
              </sec>
            </sec>
            <sec sec-type="discussion" id="sec4-biomedicines-10-00138">
              <title>4. Discussion</title>
              <p>Ca<sup>2+</sup> quantification techniques like electrophysiology and imaging-based techniques like fluorescence microscopy and plate reader-based assays suffer from hardware artifacts when operating under conditions with varying acceleration during a parabolic flight [<xref rid="B22-biomedicines-10-00138" ref-type="bibr">22</xref>]. Sophisticated controls and mathematical models are needed to decipher the actual gravity-elicited Ca<sup>2+</sup> changes and control for hardware artifacts [<xref rid="B22-biomedicines-10-00138" ref-type="bibr">22</xref>], further minimizing the throughput of such techniques. With CaMPARI2, we introduce a new reporter for Ca<sup>2+</sup> quantification to microgravity experiments. Due to its retrograde nature, the quantification takes place post-treatment. Therefore, the quantification does not suffer from hardware artifacts due to changes in g-levels, and hardware can be much cheaper and smaller than with previous techniques, allowing for a much higher throughput of experimental conditions. Furthermore, compared to a plate reader, cells transfected with CaMPARI2 combined with a high-throughput microscope, like the Incucyte S3, offer single-cell resolution with a much better signal-to-noise ratio than plate readers.</p>
              <p>It has been suggested that changes in gravity affect membrane fluidity, thereby leading to altered gating properties of mechanosensitive channels [<xref rid="B16-biomedicines-10-00138" ref-type="bibr">16</xref>]. Chondrocytes are prime examples of cells that perceive mechanical signals from their environment and modulate their metabolic activity accordingly [<xref rid="B22-biomedicines-10-00138" ref-type="bibr">22</xref>]. It has also been shown that mechanical stimulation in these cells using a glass micropipette elicits an immediate and transient increase in intracellular Ca<sup>2+</sup> levels [<xref rid="B54-biomedicines-10-00138" ref-type="bibr">54</xref>]. Furthermore, chicken chondrocytes have been treated with clinorotation at 30 rpm for up to 48 h. The intracellular Ca<sup>2+</sup> concentration was measured using Fura-2/AM to test for the effect of microgravity on chondrocytes [<xref rid="B70-biomedicines-10-00138" ref-type="bibr">70</xref>]. Ca<sup>2+</sup> levels decreased in control cells at normal gravity and in clinorotated cells, but the decrease was slightly more pronounced in the clinorotated cells. However, the variations between experiments were substantial, questioning the statistical significance of the results. </p>
              <p>An increase of intracellular Ca<sup>2+</sup> in response to changes in gravity was also detected using another cell line and the Fura-3-AM dye. The relative fluorescence of the dye in SH-SY5Y cells increased within 5 s by 0.8% upon clinorotation at 60 rpm, and by 0.7% upon transition from normal gravity to microgravity in a parabolic flight, with a 1.6% decrease in the hypergravity phase [<xref rid="B21-biomedicines-10-00138" ref-type="bibr">21</xref>]. Interestingly, in another study, the same cells showed a 2% increase in hypergravity and a 2% increase in the following microgravity and hypergravity phases [<xref rid="B17-biomedicines-10-00138" ref-type="bibr">17</xref>]. These contrasting results must be further put into perspective, considering that histamine-induced intracellular calcium levels increased by 300% in our positive control. This magnitude of the increase is more in line with what could be expected from a biological stimulus, including what has been measured for mechanical stimulation in chondrocytes [<xref rid="B54-biomedicines-10-00138" ref-type="bibr">54</xref>]. Therefore, this study aimed to determine if acceleration changes during a parabolic flight can elicit a cytosolic Ca<sup>2+</sup> increase in single cells, particularly in chondrocytes, and if so, what signaling pathways and components might be involved in this response.</p>
              <p>Using histamine as a cytosolic Ca<sup>2+</sup> elicitor with a known biological function, we selected CaMPARI2 variants with suitable Ca<sup>2+</sup> affinities. The cytosolic Ca<sup>2+</sup> concentration in mammalian cells ranges between 100 and 200 nM [<xref rid="B67-biomedicines-10-00138" ref-type="bibr">67</xref>]. Histamine increases the cytosolic Ca<sup>2+</sup> concentration for several seconds up to 1 mM [<xref rid="B71-biomedicines-10-00138" ref-type="bibr">71</xref>]. Therefore, CaMPARI2 and CaMPARI2-F391W appeared the most suitable variants for working with mammalian cell culture because of their ability to measure small changes in intracellular Ca<sup>2+</sup> concentration. Using CaMPARI2-F391W as an example, we could show that the high affinity to Ca<sup>2+</sup> already leads to a conversion of 10% of cells transfected with CaMPARI2-F391W without any stimulus when illuminated for 8 s with 405 nm light (compare <xref rid="biomedicines-10-00138-f004" ref-type="fig">Figure 4</xref>). Therefore, even small increases in cytosolic Ca<sup>2+</sup> concentrations during this 8 s of illumination would lead to a visible increase in conversion. However, based on the presented data, we conclude that C28/I2 human chondrocyte cells do not respond with Ca<sup>2+</sup> elevation changes to changes in gravity in the observed range of 0–1.8 g. These results align with a parallel experiment, also using C28/I2 cells, performed in the same parabolic flight using a plate reader, two different Ca<sup>2+</sup> dyes, and fixed control cells [<xref rid="B22-biomedicines-10-00138" ref-type="bibr">22</xref>]. It would, however, be beneficial to perform further experiments with different cell types to accommodate for the different repertoire of ion channels, transporters, and receptors in these cells. Also, platforms that offer longer timeframes of hyper- and microgravity and cleaner gravity phases without prior hypergravity treatment would benefit such studies. Once a cell line is found that displays changes in Ca<sup>2+</sup>, CaMPARI2 can be used to perform full-scale pharmacological screens and threshold experiments to identify the level of gravity required to elicit changes in Ca<sup>2+</sup> and the underlying signaling pathways.</p>
              <p>This manuscript already presents a small example of such a pharmacological study. Using different Ca<sup>2+</sup> and histamine pathway inhibitors, we identified crucial transporters involved in the histamine signaling and subsequent cytosolic Ca<sup>2+</sup> increase (<xref rid="biomedicines-10-00138-f009" ref-type="fig">Figure 9</xref>). Two of the inhibitors, Gd<sup>3+</sup> and Ruthenium red, did not significantly affect the cytosolic Ca<sup>2+</sup> increase after histamine stimulus. Since both chemicals are described as inhibitors for Transient receptor potential vanilloid 4 (TRPV4) [<xref rid="B72-biomedicines-10-00138" ref-type="bibr">72</xref>,<xref rid="B73-biomedicines-10-00138" ref-type="bibr">73</xref>], and in the case of Gd<sup>3+</sup> also as an inhibitor for stretch-activated ion channels (SACs) [<xref rid="B74-biomedicines-10-00138" ref-type="bibr">74</xref>], we can conclude that these channels are not involved in the histamine-induced Ca<sup>2+</sup> increase. On the other hand, GSK2193874, a specific inhibitor for the TRPV4 channel (<xref rid="biomedicines-10-00138-f009" ref-type="fig">Figure 9</xref>) [<xref rid="B65-biomedicines-10-00138" ref-type="bibr">65</xref>], reduced the photoconversion of CaMPARI2-F391W compared to the untreated C28/I2 cells by 50% (compare <xref rid="biomedicines-10-00138-f007" ref-type="fig">Figure 7</xref>). However, GSK2193874 was described to have an off-target effect on the voltage-gated Ca<sup>2+</sup> channel CACNA1C with an IC<sub>30</sub> value of 10.5 µM. Therefore, this result could indicate that voltage-dependent Ca<sup>2+</sup> channels may be involved in histamine signaling. </p>
              <p>Thapsigargin, a Sarco/endoplasmic reticulum Ca<sup>2+</sup>-ATPase (SERCA) inhibitor [<xref rid="B75-biomedicines-10-00138" ref-type="bibr">75</xref>], caused complete inhibition of CaMPARI2 photoconversion, indicating the ER’s primary role in histamine-induced Ca<sup>2+</sup>-elevations [<xref rid="B76-biomedicines-10-00138" ref-type="bibr">76</xref>]. After inhibition, the SERCA cannot transfer Ca<sup>2+</sup> ions into its main store, the endoplasmatic reticulum (ER), which depletes Ca<sup>2+</sup> ions after a few hours, preventing histamine-induced cytosolic Ca<sup>2+</sup> increases originating from ER stores. Flunarizine, an antihistamine and Ca<sup>2+</sup> entry blocker [<xref rid="B77-biomedicines-10-00138" ref-type="bibr">77</xref>], also fully inhibited a histamine-induced increase in cytosolic Ca<sup>2+</sup> (<xref rid="biomedicines-10-00138-f007" ref-type="fig">Figure 7</xref>). Flunarizine is a blocker of the H1R histamine receptor, suggesting that histamine-induced Ca<sup>2+</sup>-elevations originate from H1R. It is also known to block voltage-gated calcium channels and might exert a dual inhibitory function in histamine signaling [<xref rid="B62-biomedicines-10-00138" ref-type="bibr">62</xref>,<xref rid="B63-biomedicines-10-00138" ref-type="bibr">63</xref>]. However, further genetic or pharmacological studies will be necessary to confirm this hypothesis. Using CaMPARI2 as a high throughput analysis tool, large-scale pharmacological screens can be used to identify components involved in histamine signaling upstream of cytosolic Ca<sup>2+</sup> increase. </p>
              <p>In summary, we successfully implemented a high-throughput analysis of cytosolic Ca<sup>2+</sup> concentration using CaMPARI2 photoconversion as a readout. This system is suitable for environments with varying accelerations and can be used for large-scale pathways analysis with pharmacological libraries in the future. </p>
            </sec>
          </body>
          <back>
            <ack>
              <title>Acknowledgments</title>
              <p>We would like to express our gratitude to Sartorius for providing the IncuCyte S3 and personnel on-site in Bordeaux and their support in analyzing the data. We thank the European Space Agency (ESA) and Novespace (Bordeaux, France) for the organization of and support during the parabolic flight campaign.</p>
            </ack>
            <fn-group>
              <fn>
                <p><bold>Publisher’s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
              </fn>
            </fn-group>
            <app-group>
              <app id="app1-biomedicines-10-00138">
                <title>Supplementary Materials</title>
                <p>The following are available online at <uri xlink:href="https://www.mdpi.com/article/10.3390/biomedicines10010138/s1">https://www.mdpi.com/article/10.3390/biomedicines10010138/s1</uri>. Figure S1: Different metrics used to analyze high throughput microscopy image data after the parabolic flight. Figure S2: Conversion rates of cells transfected with CaMPARI2 and subjected to a parabolic flight. Figure S3: Z’-Factor analysis of all four parabolas of the second and third parabolic flight.</p>
                <supplementary-material id="biomedicines-10-00138-s001" position="float" content-type="local-data">
                  <media xlink:href="biomedicines-10-00138-s001.zip">
                    <caption>
                      <p>Click here for additional data file.</p>
                    </caption>
                  </media>
                </supplementary-material>
              </app>
            </app-group>
            <notes>
              <title>Author Contributions</title>
              <p>Conceptualization, S.L.W. and M.B.; Data curation, A.H., D.A.R. and M.B.; Formal analysis, A.H., D.A.R. and M.B.; Funding acquisition, M.E., E.S., S.L.W. and M.B.; Investigation, A.H., G.C., D.A.R., K.F.R.-K. and S.L.W.; Methodology, A.H., D.S., S.M., C.Z., S.v.A., S.A., F.S., R.B., A.S., S.L.W. and M.B.; Project administration, S.L.W. and M.B.; Resources, F.S., R.B., A.S., E.H.K.S., M.E., E.S., S.L.W. and M.B.; Software, A.H., D.A.R., R.K., S.L.W. and M.B.; Supervision, F.S., E.H.K.S., E.S., S.L.W. and M.B.; Validation, A.H., D.S., S.M., C.Z., S.v.A., S.A. and S.L.W.; Visualization, A.H., D.A.R. and M.B.; Writing—original draft, A.H. and M.B.; Writing—review &amp; editing, A.H., D.A.R., F.S., A.S., E.H.K.S., S.L.W. and M.B. All authors have read and agreed to the published version of the manuscript.</p>
            </notes>
            <notes>
              <title>Funding</title>
              <p>We gratefully acknowledge financial support to S.L.W. and M.E. through PRODEX (ESA), and the Swiss Space Office (SSO), and to M.B. and E.S. through the German Space Agency (DLR) with funds provided by the Federal Ministry for Economic Affairs and Energy (BMWi) due to enactment of the German Bundestag under Grant No. DLR 50WB1830 and 50WB2130. Parabolic flights were funded by the European Space Agency (ESA).</p>
            </notes>
            <notes>
              <title>Institutional Review Board Statement</title>
              <p>Not applicable.</p>
            </notes>
            <notes>
              <title>Informed Consent Statement</title>
              <p>Not applicable.</p>
            </notes>
            <notes notes-type="data-availability">
              <title>Data Availability Statement</title>
              <p>The quantitative imaging data and software codes (release 1.0) presented in this study are openly available in <uri xlink:href="https://github.com/ZeroG-lab/PFCaMPARI">https://github.com/ZeroG-lab/PFCaMPARI</uri> at doi:10.5281/zenodo.5824491. Raw images are available on request from the corresponding author (M.B.).</p>
            </notes>
            <notes notes-type="COI-statement">
              <title>Conflicts of Interest</title>
              <p>The authors declare no conflict of interest. The funders had no role in the study’s design, in the collection, analyses, or interpretation of data, in the writing of the manuscript, or in the decision to publish the results.</p>
            </notes>
            <ref-list>
              <title>References</title>
              <ref id="B1-biomedicines-10-00138">
                <label>1.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hardingham</surname>
                      <given-names>G.E.</given-names>
                    </name>
                    <name>
                      <surname>Bading</surname>
                      <given-names>H.</given-names>
                    </name>
                  </person-group>
                  <article-title>Calcium as a Versatile Second Messenger in the Control of Gene Expression</article-title>
                  <source>Microsc. Res. Tech.</source>
                  <year>1999</year>
                  <volume>46</volume>
                  <fpage>348</fpage>
                  <lpage>355</lpage>
                  <pub-id pub-id-type="doi">10.1002/(SICI)1097-0029(19990915)46:6&lt;348::AID-JEMT3&gt;3.0.CO;2-A</pub-id>
                  <pub-id pub-id-type="pmid">10504212</pub-id>
                </element-citation>
              </ref>
              <ref id="B2-biomedicines-10-00138">
                <label>2.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Brini</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Calì</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Ottolini</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Carafoli</surname>
                      <given-names>E.</given-names>
                    </name>
                  </person-group>
                  <article-title>Intracellular Calcium Homeostasis and Signaling</article-title>
                  <source>Metallomics and the Cell. Metal Ions in Life Sciences</source>
                  <person-group person-group-type="editor">
                    <name>
                      <surname>Banci</surname>
                      <given-names>L.</given-names>
                    </name>
                  </person-group>
                  <publisher-name>Springer</publisher-name>
                  <publisher-loc>Dordrecht, The Netherlands</publisher-loc>
                  <year>2013</year>
                  <volume>Volume 12</volume>
                  <fpage>119</fpage>
                  <lpage>168</lpage>
                  <pub-id pub-id-type="doi">10.1007/978-94-007-5561-1_5</pub-id>
                </element-citation>
              </ref>
              <ref id="B3-biomedicines-10-00138">
                <label>3.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kekenes-Huskey</surname>
                      <given-names>P.M.</given-names>
                    </name>
                    <name>
                      <surname>Metzger</surname>
                      <given-names>V.T.</given-names>
                    </name>
                    <name>
                      <surname>Grant</surname>
                      <given-names>B.J.</given-names>
                    </name>
                    <name>
                      <surname>Andrew McCammon</surname>
                      <given-names>J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Calcium Binding and Allosteric Signaling Mechanisms for the Sarcoplasmic Reticulum Ca<sup>2+</sup> ATPase</article-title>
                  <source>Protein Sci.</source>
                  <year>2012</year>
                  <volume>21</volume>
                  <fpage>1429</fpage>
                  <lpage>1443</lpage>
                  <pub-id pub-id-type="doi">10.1002/pro.2129</pub-id>
                  <?supplied-pmid 22821874?>
                  <pub-id pub-id-type="pmid">22821874</pub-id>
                </element-citation>
              </ref>
              <ref id="B4-biomedicines-10-00138">
                <label>4.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lane</surname>
                      <given-names>J.M.</given-names>
                    </name>
                    <name>
                      <surname>Russell</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Khan</surname>
                      <given-names>S.N.</given-names>
                    </name>
                  </person-group>
                  <article-title>Osteoporosis</article-title>
                  <source>Clin. Orthop. Relat. Res.</source>
                  <year>2000</year>
                  <volume>372</volume>
                  <fpage>139</fpage>
                  <lpage>150</lpage>
                  <pub-id pub-id-type="doi">10.1097/00003086-200003000-00016</pub-id>
                  <?supplied-pmid 10738423?>
                  <pub-id pub-id-type="pmid">10738423</pub-id>
                </element-citation>
              </ref>
              <ref id="B5-biomedicines-10-00138">
                <label>5.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Liang</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Kulasiri</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Samarasinghe</surname>
                      <given-names>S.</given-names>
                    </name>
                  </person-group>
                  <article-title>Ca<sup>2+</sup> Dysregulation in the Endoplasmic Reticulum Related to Alzheimer’s Disease: A Review on Experimental Progress and Computational Modeling</article-title>
                  <source>Biosystems</source>
                  <year>2015</year>
                  <volume>134</volume>
                  <fpage>1</fpage>
                  <lpage>15</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.biosystems.2015.05.003</pub-id>
                  <pub-id pub-id-type="pmid">25998697</pub-id>
                </element-citation>
              </ref>
              <ref id="B6-biomedicines-10-00138">
                <label>6.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lee</surname>
                      <given-names>E.H.</given-names>
                    </name>
                  </person-group>
                  <article-title>Ca<sup>2+</sup> Channels and Skeletal Muscle Diseases</article-title>
                  <source>Prog. Biophys. Mol. Biol.</source>
                  <year>2010</year>
                  <volume>103</volume>
                  <fpage>35</fpage>
                  <lpage>43</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.pbiomolbio.2010.05.003</pub-id>
                  <pub-id pub-id-type="pmid">20553745</pub-id>
                </element-citation>
              </ref>
              <ref id="B7-biomedicines-10-00138">
                <label>7.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bruton</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Cheng</surname>
                      <given-names>A.J.</given-names>
                    </name>
                    <name>
                      <surname>Westerblad</surname>
                      <given-names>H.</given-names>
                    </name>
                  </person-group>
                  <article-title>Measuring Ca<sup>2+</sup> in Living Cells</article-title>
                  <source>Calcium Signaling. Advances in Experimental Medicine and Biology</source>
                  <person-group person-group-type="editor">
                    <name>
                      <surname>Islam</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <publisher-name>Springer</publisher-name>
                  <publisher-loc>Cham, Switzerland</publisher-loc>
                  <year>2020</year>
                  <volume>Volume 1131</volume>
                  <fpage>7</fpage>
                  <lpage>26</lpage>
                  <pub-id pub-id-type="doi">10.1007/978-3-030-12457-1_2</pub-id>
                </element-citation>
              </ref>
              <ref id="B8-biomedicines-10-00138">
                <label>8.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Grynkiewicz</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Poenie</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Tsien</surname>
                      <given-names>R.Y.</given-names>
                    </name>
                  </person-group>
                  <article-title>A New Generation of Ca<sup>2+</sup> Indicators with Greatly Improved Fluorescence Properties</article-title>
                  <source>J. Biol. Chem.</source>
                  <year>1985</year>
                  <volume>260</volume>
                  <fpage>3440</fpage>
                  <lpage>3450</lpage>
                  <pub-id pub-id-type="doi">10.1016/S0021-9258(19)83641-4</pub-id>
                  <pub-id pub-id-type="pmid">3838314</pub-id>
                </element-citation>
              </ref>
              <ref id="B9-biomedicines-10-00138">
                <label>9.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zhao</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Araki</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Wu</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Teramoto</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Chang</surname>
                      <given-names>Y.-F.</given-names>
                    </name>
                    <name>
                      <surname>Nakano</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Abdelfattah</surname>
                      <given-names>A.S.</given-names>
                    </name>
                    <name>
                      <surname>Fujiwara</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Ishihara</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Nagai</surname>
                      <given-names>T.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>An Expanded Palette of Genetically Encoded Ca<sup>2+</sup> Indicators</article-title>
                  <source>Science</source>
                  <year>2011</year>
                  <volume>333</volume>
                  <fpage>1888</fpage>
                  <lpage>1891</lpage>
                  <pub-id pub-id-type="doi">10.1126/science.1208592</pub-id>
                  <?supplied-pmid 21903779?>
                  <pub-id pub-id-type="pmid">21903779</pub-id>
                </element-citation>
              </ref>
              <ref id="B10-biomedicines-10-00138">
                <label>10.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chen</surname>
                      <given-names>T.-W.</given-names>
                    </name>
                    <name>
                      <surname>Wardill</surname>
                      <given-names>T.J.</given-names>
                    </name>
                    <name>
                      <surname>Sun</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Pulver</surname>
                      <given-names>S.R.</given-names>
                    </name>
                    <name>
                      <surname>Renninger</surname>
                      <given-names>S.L.</given-names>
                    </name>
                    <name>
                      <surname>Baohan</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Schreiter</surname>
                      <given-names>E.R.</given-names>
                    </name>
                    <name>
                      <surname>Kerr</surname>
                      <given-names>R.A.</given-names>
                    </name>
                    <name>
                      <surname>Orger</surname>
                      <given-names>M.B.</given-names>
                    </name>
                    <name>
                      <surname>Jayaraman</surname>
                      <given-names>V.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Ultrasensitive Fluorescent Proteins for Imaging Neuronal Activity</article-title>
                  <source>Nature</source>
                  <year>2013</year>
                  <volume>499</volume>
                  <fpage>295</fpage>
                  <lpage>300</lpage>
                  <pub-id pub-id-type="doi">10.1038/nature12354</pub-id>
                  <pub-id pub-id-type="pmid">23868258</pub-id>
                </element-citation>
              </ref>
              <ref id="B11-biomedicines-10-00138">
                <label>11.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Keinath</surname>
                      <given-names>N.F.</given-names>
                    </name>
                    <name>
                      <surname>Waadt</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Brugman</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Schroeder</surname>
                      <given-names>J.I.</given-names>
                    </name>
                    <name>
                      <surname>Grossmann</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Schumacher</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Krebs</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Live Cell Imaging with R-GECO1 Sheds Light on Flg22- and Chitin-Induced Transient [Ca<sup>2+</sup>]<sub>Cyt</sub> Patterns in Arabidopsis</article-title>
                  <source>Mol. Plant</source>
                  <year>2015</year>
                  <volume>8</volume>
                  <fpage>1188</fpage>
                  <lpage>1200</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.molp.2015.05.006</pub-id>
                  <pub-id pub-id-type="pmid">26002145</pub-id>
                </element-citation>
              </ref>
              <ref id="B12-biomedicines-10-00138">
                <label>12.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rodriguez</surname>
                      <given-names>E.A.</given-names>
                    </name>
                    <name>
                      <surname>Campbell</surname>
                      <given-names>R.E.</given-names>
                    </name>
                    <name>
                      <surname>Lin</surname>
                      <given-names>J.Y.</given-names>
                    </name>
                    <name>
                      <surname>Lin</surname>
                      <given-names>M.Z.</given-names>
                    </name>
                    <name>
                      <surname>Miyawaki</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Palmer</surname>
                      <given-names>A.E.</given-names>
                    </name>
                    <name>
                      <surname>Shu</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Tsien</surname>
                      <given-names>R.Y.</given-names>
                    </name>
                  </person-group>
                  <article-title>The Growing and Glowing Toolbox of Fluorescent and Photoactive Proteins</article-title>
                  <source>Trends Biochem. Sci.</source>
                  <year>2017</year>
                  <volume>42</volume>
                  <fpage>111</fpage>
                  <lpage>129</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.tibs.2016.09.010</pub-id>
                  <pub-id pub-id-type="pmid">27814948</pub-id>
                </element-citation>
              </ref>
              <ref id="B13-biomedicines-10-00138">
                <label>13.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fosque</surname>
                      <given-names>B.F.</given-names>
                    </name>
                    <name>
                      <surname>Sun</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Dana</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Yang</surname>
                      <given-names>C.-T.</given-names>
                    </name>
                    <name>
                      <surname>Ohyama</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Tadross</surname>
                      <given-names>M.R.</given-names>
                    </name>
                    <name>
                      <surname>Patel</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Zlatic</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Kim</surname>
                      <given-names>D.S.</given-names>
                    </name>
                    <name>
                      <surname>Ahrens</surname>
                      <given-names>M.B.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Labeling of Active Neural Circuits in Vivo with Designed Calcium Integrators</article-title>
                  <source>Science</source>
                  <year>2015</year>
                  <volume>347</volume>
                  <fpage>755</fpage>
                  <lpage>760</lpage>
                  <pub-id pub-id-type="doi">10.1126/science.1260922</pub-id>
                  <pub-id pub-id-type="pmid">25678659</pub-id>
                </element-citation>
              </ref>
              <ref id="B14-biomedicines-10-00138">
                <label>14.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Moeyaert</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Holt</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Madangopal</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Perez-Alvarez</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Fearey</surname>
                      <given-names>B.C.</given-names>
                    </name>
                    <name>
                      <surname>Trojanowski</surname>
                      <given-names>N.F.</given-names>
                    </name>
                    <name>
                      <surname>Ledderose</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Zolnik</surname>
                      <given-names>T.A.</given-names>
                    </name>
                    <name>
                      <surname>Das</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Patel</surname>
                      <given-names>D.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Improved Methods for Marking Active Neuron Populations</article-title>
                  <source>Nat. Commun.</source>
                  <year>2018</year>
                  <volume>9</volume>
                  <pub-id pub-id-type="doi">10.1038/s41467-018-06935-2</pub-id>
                </element-citation>
              </ref>
              <ref id="B15-biomedicines-10-00138">
                <label>15.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zolnik</surname>
                      <given-names>T.A.</given-names>
                    </name>
                    <name>
                      <surname>Sha</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Johenning</surname>
                      <given-names>F.W.</given-names>
                    </name>
                    <name>
                      <surname>Schreiter</surname>
                      <given-names>E.R.</given-names>
                    </name>
                    <name>
                      <surname>Looger</surname>
                      <given-names>L.L.</given-names>
                    </name>
                    <name>
                      <surname>Larkum</surname>
                      <given-names>M.E.</given-names>
                    </name>
                    <name>
                      <surname>Sachdev</surname>
                      <given-names>R.N.S.</given-names>
                    </name>
                  </person-group>
                  <article-title>All-Optical Functional Synaptic Connectivity Mapping in Acute Brain Slices Using the Calcium Integrator CaMPARI</article-title>
                  <source>J. Physiol.</source>
                  <year>2017</year>
                  <volume>595</volume>
                  <fpage>1465</fpage>
                  <lpage>1477</lpage>
                  <pub-id pub-id-type="doi">10.1113/JP273116</pub-id>
                  <pub-id pub-id-type="pmid">27861906</pub-id>
                </element-citation>
              </ref>
              <ref id="B16-biomedicines-10-00138">
                <label>16.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wuest</surname>
                      <given-names>S.L.</given-names>
                    </name>
                    <name>
                      <surname>Gantenbein</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Ille</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Egli</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Electrophysiological Experiments in Microgravity: Lessons Learned and Future Challenges</article-title>
                  <source>NPJ Microgravity</source>
                  <year>2018</year>
                  <volume>4</volume>
                  <fpage>1</fpage>
                  <lpage>7</lpage>
                  <pub-id pub-id-type="doi">10.1038/s41526-018-0042-3</pub-id>
                  <pub-id pub-id-type="pmid">29354685</pub-id>
                </element-citation>
              </ref>
              <ref id="B17-biomedicines-10-00138">
                <label>17.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kohn</surname>
                      <given-names>F.P.M.</given-names>
                    </name>
                  </person-group>
                  <article-title>High Throughput Fluorescent Screening of Membrane Potential and Intracellular Calcium Concentration Under Variable Gravity Conditions</article-title>
                  <source>Microgravity Sci. Technol.</source>
                  <year>2013</year>
                  <volume>25</volume>
                  <fpage>113</fpage>
                  <lpage>120</lpage>
                  <pub-id pub-id-type="doi">10.1007/s12217-012-9331-8</pub-id>
                </element-citation>
              </ref>
              <ref id="B18-biomedicines-10-00138">
                <label>18.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ditengou</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Legué</surname>
                      <given-names>V.</given-names>
                    </name>
                    <name>
                      <surname>Brugman</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Pereda-Loth</surname>
                      <given-names>V.</given-names>
                    </name>
                    <name>
                      <surname>Schültze</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Tisseyre</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Rapp</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Oltmann</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Feldmann</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Cordes</surname>
                      <given-names>P.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Use of FLUMIAS to Reveal Dynamic Cellular Changes Initiated by Statolith Movement in Arabidopsis Thaliana Root Cells: First Observations from Parabolic Flight Campaign</article-title>
                  <source>Workshop “Human Spaceflight and Weightlessness Science”</source>
                  <publisher-name>CNES</publisher-name>
                  <publisher-loc>Toulouse, France</publisher-loc>
                  <year>2018</year>
                </element-citation>
              </ref>
              <ref id="B19-biomedicines-10-00138">
                <label>19.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Corydon</surname>
                      <given-names>T.J.</given-names>
                    </name>
                    <name>
                      <surname>Kopp</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Wehland</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Braun</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Schütte</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Mayer</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Hülsing</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Oltmann</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Schmitz</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Hemmersbach</surname>
                      <given-names>R.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Alterations of the Cytoskeleton in Human Cells in Space Proved by Life-Cell Imaging</article-title>
                  <source>Sci. Rep.</source>
                  <year>2016</year>
                  <volume>6</volume>
                  <fpage>1</fpage>
                  <lpage>14</lpage>
                  <pub-id pub-id-type="doi">10.1038/srep20043</pub-id>
                  <?supplied-pmid 26818711?>
                  <pub-id pub-id-type="pmid">28442746</pub-id>
                </element-citation>
              </ref>
              <ref id="B20-biomedicines-10-00138">
                <label>20.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Thiel</surname>
                      <given-names>C.S.</given-names>
                    </name>
                    <name>
                      <surname>Tauber</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Seebacher</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Schropp</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Uhl</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Lauber</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Polzer</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Neelam</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Ullrich</surname>
                      <given-names>O.</given-names>
                    </name>
                  </person-group>
                  <article-title>Real-Time 3D High-Resolution Microscopy of Human Cells on the International Space Station</article-title>
                  <source>Int. J. Mol. Sci.</source>
                  <year>2019</year>
                  <volume>20</volume>
                  <elocation-id>2033</elocation-id>
                  <pub-id pub-id-type="doi">10.3390/ijms20082033</pub-id>
                  <?supplied-pmid 31027161?>
                  <pub-id pub-id-type="pmid">31027161</pub-id>
                </element-citation>
              </ref>
              <ref id="B21-biomedicines-10-00138">
                <label>21.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hauslage</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Abbrecht</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Hanke</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Hemmersbach</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Koch</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Hanke</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Kohn</surname>
                      <given-names>F.P.M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Cytosolic Calcium Concentration Changes in Neuronal Cells Under Clinorotation and in Parabolic Flight Missions</article-title>
                  <source>Microgravity Sci. Technol.</source>
                  <year>2016</year>
                  <volume>28</volume>
                  <fpage>633</fpage>
                  <lpage>638</lpage>
                  <pub-id pub-id-type="doi">10.1007/s12217-016-9520-y</pub-id>
                </element-citation>
              </ref>
              <ref id="B22-biomedicines-10-00138">
                <label>22.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wüest</surname>
                      <given-names>S.L.</given-names>
                    </name>
                    <name>
                      <surname>Cerretti</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Wadsworth</surname>
                      <given-names>J.L.</given-names>
                    </name>
                    <name>
                      <surname>Follonier</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Rattenbacher-Kiser</surname>
                      <given-names>K.F.</given-names>
                    </name>
                    <name>
                      <surname>Bradley</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Egli</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Ille</surname>
                      <given-names>F.</given-names>
                    </name>
                  </person-group>
                  <article-title>Cytosolic Calcium and Membrane Potential in Articular Chondrocytes during Parabolic Flight</article-title>
                  <source>Acta Astronaut.</source>
                  <comment>in revision</comment>
                </element-citation>
              </ref>
              <ref id="B23-biomedicines-10-00138">
                <label>23.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Clark</surname>
                      <given-names>R.B.</given-names>
                    </name>
                    <name>
                      <surname>Schmidt</surname>
                      <given-names>T.A.</given-names>
                    </name>
                    <name>
                      <surname>Sachse</surname>
                      <given-names>F.B.</given-names>
                    </name>
                    <name>
                      <surname>Boyle</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Firestein</surname>
                      <given-names>G.S.</given-names>
                    </name>
                    <name>
                      <surname>Giles</surname>
                      <given-names>W.R.</given-names>
                    </name>
                  </person-group>
                  <article-title>Cellular Electrophysiological Principles That Modulate Secretion from Synovial Fibroblasts</article-title>
                  <source>J. Physiol.</source>
                  <year>2017</year>
                  <volume>595</volume>
                  <fpage>635</fpage>
                  <lpage>645</lpage>
                  <pub-id pub-id-type="doi">10.1113/JP270209</pub-id>
                  <?supplied-pmid 27079855?>
                  <pub-id pub-id-type="pmid">27079855</pub-id>
                </element-citation>
              </ref>
              <ref id="B24-biomedicines-10-00138">
                <label>24.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mobasheri</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Batt</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>An Update on the Pathophysiology of Osteoarthritis</article-title>
                  <source>Ann. Phys. Rehabil. Med.</source>
                  <year>2016</year>
                  <volume>59</volume>
                  <fpage>333</fpage>
                  <lpage>339</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.rehab.2016.07.004</pub-id>
                  <?supplied-pmid 27546496?>
                  <pub-id pub-id-type="pmid">27546496</pub-id>
                </element-citation>
              </ref>
              <ref id="B25-biomedicines-10-00138">
                <label>25.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chen</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Shen</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Zhao</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Han</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Hamilton</surname>
                      <given-names>J.L.</given-names>
                    </name>
                    <name>
                      <surname>Im</surname>
                      <given-names>H.J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Osteoarthritis: Toward a Comprehensive Understanding of Pathological Mechanism</article-title>
                  <source>Bone Res.</source>
                  <year>2017</year>
                  <volume>5</volume>
                  <pub-id pub-id-type="doi">10.1038/boneres.2016.44</pub-id>
                  <?supplied-pmid 28149655?>
                  <pub-id pub-id-type="pmid">28149655</pub-id>
                </element-citation>
              </ref>
              <ref id="B26-biomedicines-10-00138">
                <label>26.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sun</surname>
                      <given-names>M.M.G.</given-names>
                    </name>
                    <name>
                      <surname>Beier</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Pest</surname>
                      <given-names>M.A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Recent Developments in Emerging Therapeutic Targets of Osteoarthritis</article-title>
                  <source>Curr. Opin. Rheumatol.</source>
                  <year>2017</year>
                  <volume>29</volume>
                  <fpage>96</fpage>
                  <lpage>102</lpage>
                  <pub-id pub-id-type="doi">10.1097/BOR.0000000000000351</pub-id>
                  <?supplied-pmid 27906752?>
                  <pub-id pub-id-type="pmid">27906752</pub-id>
                </element-citation>
              </ref>
              <ref id="B27-biomedicines-10-00138">
                <label>27.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sugita</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Hosaka</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Okada</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Mori</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Yano</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Kobayashi</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Taniguchi</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Mori</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Okuma</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Chang</surname>
                      <given-names>S.H.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Transcription Factor Hes1 Modulates Osteoarthritis Development in Cooperation with Calcium/Calmodulin-Dependent Protein Kinase 2</article-title>
                  <source>Proc. Natl. Acad. Sci. USA</source>
                  <year>2015</year>
                  <volume>112</volume>
                  <fpage>3080</fpage>
                  <lpage>3085</lpage>
                  <pub-id pub-id-type="doi">10.1073/pnas.1419699112</pub-id>
                  <pub-id pub-id-type="pmid">25733872</pub-id>
                </element-citation>
              </ref>
              <ref id="B28-biomedicines-10-00138">
                <label>28.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wei</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Jin</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Piao</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Lu</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Bai</surname>
                      <given-names>L.</given-names>
                    </name>
                  </person-group>
                  <article-title>The Transient Receptor Potential Channel, Vanilloid 5, Induces Chondrocyte Apoptosis via Ca<sup>2+</sup> CaMKII-Dependent MAPK and Akt/ MTOR Pathways in a Rat Osteoarthritis Model</article-title>
                  <source>Cell. Physiol. Biochem.</source>
                  <year>2018</year>
                  <volume>51</volume>
                  <fpage>2309</fpage>
                  <lpage>2323</lpage>
                  <pub-id pub-id-type="doi">10.1159/000495874</pub-id>
                  <pub-id pub-id-type="pmid">30537737</pub-id>
                </element-citation>
              </ref>
              <ref id="B29-biomedicines-10-00138">
                <label>29.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Yao</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Han</surname>
                      <given-names>Q.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Niu</surname>
                      <given-names>Z.</given-names>
                    </name>
                  </person-group>
                  <article-title>Ropivacaine Relieves Pain and Prevents Chondrocyte Degradation Probably through Calcineurin/NFAT1 Signaling Pathway in Osteoarthritis Rats</article-title>
                  <source>Eur. J. Pharmacol.</source>
                  <year>2018</year>
                  <volume>818</volume>
                  <fpage>518</fpage>
                  <lpage>524</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.ejphar.2017.11.030</pub-id>
                  <pub-id pub-id-type="pmid">29157984</pub-id>
                </element-citation>
              </ref>
              <ref id="B30-biomedicines-10-00138">
                <label>30.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Partsch</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Schwagerl</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Eberl</surname>
                      <given-names>R.</given-names>
                    </name>
                  </person-group>
                  <article-title>Untersuchungen über Histamin bei rheumatischen Erkrankungen</article-title>
                  <source>Z. Für Rheumatol.</source>
                  <year>1982</year>
                  <volume>41</volume>
                  <fpage>19</fpage>
                  <lpage>22</lpage>
                </element-citation>
              </ref>
              <ref id="B31-biomedicines-10-00138">
                <label>31.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Tetlow</surname>
                      <given-names>L.C.</given-names>
                    </name>
                    <name>
                      <surname>Woolley</surname>
                      <given-names>D.E.</given-names>
                    </name>
                  </person-group>
                  <article-title>Histamine stimulates the proliferation of human articular chondrocytes in vitro and is expressed by chondrocytes in osteoarthritic cartilage</article-title>
                  <source>Ann. Rheum. Dis.</source>
                  <year>2003</year>
                  <volume>62</volume>
                  <fpage>991</fpage>
                  <lpage>994</lpage>
                  <pub-id pub-id-type="doi">10.1136/ard.62.10.991</pub-id>
                  <pub-id pub-id-type="pmid">12972479</pub-id>
                </element-citation>
              </ref>
              <ref id="B32-biomedicines-10-00138">
                <label>32.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Tetlow</surname>
                      <given-names>L.C.</given-names>
                    </name>
                    <name>
                      <surname>Woolley</surname>
                      <given-names>D.E.</given-names>
                    </name>
                  </person-group>
                  <article-title>Histamine, histamine receptors (H1 and H2), and histidine decarboxylase expression by chondrocytes of osteoarthritic cartilage: An immunohistochemical study</article-title>
                  <source>Rheumatol. Int.</source>
                  <year>2005</year>
                  <volume>26</volume>
                  <fpage>173</fpage>
                  <lpage>178</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00296-005-0622-x</pub-id>
                  <?supplied-pmid 15986084?>
                  <pub-id pub-id-type="pmid">15986084</pub-id>
                </element-citation>
              </ref>
              <ref id="B33-biomedicines-10-00138">
                <label>33.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Freemont</surname>
                      <given-names>A.J.</given-names>
                    </name>
                    <name>
                      <surname>Hampson</surname>
                      <given-names>V.</given-names>
                    </name>
                    <name>
                      <surname>Tilman</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Goupille</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Taiwo</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Hoyland</surname>
                      <given-names>J.A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Gene expression of matrix metalloproteinases 1, 3, and 9 by chondrocytes in osteoarthritic human knee articular cartilage is zone and grade specific</article-title>
                  <source>Ann. Rheum. Dis.</source>
                  <year>1997</year>
                  <volume>56</volume>
                  <fpage>542</fpage>
                  <lpage>548</lpage>
                  <pub-id pub-id-type="doi">10.1136/ard.56.9.542</pub-id>
                  <?supplied-pmid 9370879?>
                  <pub-id pub-id-type="pmid">9370879</pub-id>
                </element-citation>
              </ref>
              <ref id="B34-biomedicines-10-00138">
                <label>34.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Tetlow</surname>
                      <given-names>L.C.</given-names>
                    </name>
                    <name>
                      <surname>Adlam</surname>
                      <given-names>D.J.</given-names>
                    </name>
                    <name>
                      <surname>Woolley</surname>
                      <given-names>D.E.</given-names>
                    </name>
                  </person-group>
                  <article-title>Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: Associations with degenerative changes</article-title>
                  <source>Arthritis Rheum.</source>
                  <year>2001</year>
                  <volume>44</volume>
                  <fpage>585</fpage>
                  <lpage>594</lpage>
                  <pub-id pub-id-type="doi">10.1002/1529-0131(200103)44:3&lt;585::AID-ANR107&gt;3.0.CO;2-C</pub-id>
                  <pub-id pub-id-type="pmid">11263773</pub-id>
                </element-citation>
              </ref>
              <ref id="B35-biomedicines-10-00138">
                <label>35.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gong</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Huang</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Fu</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Song</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Yang</surname>
                      <given-names>L.</given-names>
                    </name>
                  </person-group>
                  <article-title>Synergistically Regulated Spontaneous Calcium Signaling Is Attributed to Cartilaginous Extracellular Matrix Metabolism</article-title>
                  <source>J. Cell. Physiol.</source>
                  <year>2019</year>
                  <volume>234</volume>
                  <fpage>9711</fpage>
                  <lpage>9722</lpage>
                  <pub-id pub-id-type="doi">10.1002/jcp.27657</pub-id>
                  <pub-id pub-id-type="pmid">30370672</pub-id>
                </element-citation>
              </ref>
              <ref id="B36-biomedicines-10-00138">
                <label>36.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Matta</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Fodor</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Szíjgyártó</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Juhász</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Gergely</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Csernoch</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Zákány</surname>
                      <given-names>R.</given-names>
                    </name>
                  </person-group>
                  <article-title>Cytosolic Free Ca2+ Concentration Exhibits a Characteristic Temporal Pattern during in Vitro Cartilage Differentiation: A Possible Regulatory Role of Calcineurin in Ca-Signalling of Chondrogenic Cells</article-title>
                  <source>Cell Calcium</source>
                  <year>2008</year>
                  <volume>44</volume>
                  <fpage>310</fpage>
                  <lpage>323</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.ceca.2007.12.010</pub-id>
                  <pub-id pub-id-type="pmid">18291522</pub-id>
                </element-citation>
              </ref>
              <ref id="B37-biomedicines-10-00138">
                <label>37.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lv</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Zhou</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Polson</surname>
                      <given-names>S.W.</given-names>
                    </name>
                    <name>
                      <surname>Wan</surname>
                      <given-names>L.Q.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Han</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Lu</surname>
                      <given-names>X.L.</given-names>
                    </name>
                  </person-group>
                  <article-title>Identification of Chondrocyte Genes and Signaling Pathways in Response to Acute Joint Inflammation</article-title>
                  <source>Sci. Rep.</source>
                  <year>2019</year>
                  <volume>9</volume>
                  <pub-id pub-id-type="doi">10.1038/s41598-018-36500-2</pub-id>
                </element-citation>
              </ref>
              <ref id="B38-biomedicines-10-00138">
                <label>38.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Suzuki</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Yamamura</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Imaizumi</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Clark</surname>
                      <given-names>R.B.</given-names>
                    </name>
                    <name>
                      <surname>Giles</surname>
                      <given-names>W.R.</given-names>
                    </name>
                  </person-group>
                  <article-title>K<sup>+</sup> and Ca<sup>2+</sup> Channels Regulate Ca<sup>2+</sup> Signaling in Chondrocytes: An Illustrated Review</article-title>
                  <source>Cells</source>
                  <year>2020</year>
                  <volume>9</volume>
                  <elocation-id>1577</elocation-id>
                  <pub-id pub-id-type="doi">10.3390/cells9071577</pub-id>
                </element-citation>
              </ref>
              <ref id="B39-biomedicines-10-00138">
                <label>39.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Yellowley</surname>
                      <given-names>C.E.</given-names>
                    </name>
                    <name>
                      <surname>Hancox</surname>
                      <given-names>J.C.</given-names>
                    </name>
                    <name>
                      <surname>Donahue</surname>
                      <given-names>H.J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Effects of Cell Swelling on Intracellular Calcium and Membrane Currents in Bovine Articular Chondrocytes</article-title>
                  <source>J. Cell. Biochem.</source>
                  <year>2002</year>
                  <volume>86</volume>
                  <fpage>290</fpage>
                  <lpage>301</lpage>
                  <pub-id pub-id-type="doi">10.1002/jcb.10217</pub-id>
                  <pub-id pub-id-type="pmid">12111998</pub-id>
                </element-citation>
              </ref>
              <ref id="B40-biomedicines-10-00138">
                <label>40.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Dascalu</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Korenstein</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Oron</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Nevo</surname>
                      <given-names>Z.</given-names>
                    </name>
                  </person-group>
                  <article-title>A Hyperosmotic Stimulus Regulates Intracellular PH, Calcium, and S-100 Protein Levels in Avian Chondrocytes</article-title>
                  <source>Biochem. Biophys. Res. Commun.</source>
                  <year>1996</year>
                  <volume>227</volume>
                  <fpage>368</fpage>
                  <lpage>373</lpage>
                  <pub-id pub-id-type="doi">10.1006/bbrc.1996.1514</pub-id>
                  <pub-id pub-id-type="pmid">8878522</pub-id>
                </element-citation>
              </ref>
              <ref id="B41-biomedicines-10-00138">
                <label>41.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Erickson</surname>
                      <given-names>G.R.</given-names>
                    </name>
                    <name>
                      <surname>Alexopoulos</surname>
                      <given-names>L.G.</given-names>
                    </name>
                    <name>
                      <surname>Guilak</surname>
                      <given-names>F.</given-names>
                    </name>
                  </person-group>
                  <article-title>Hyper-Osmotic Stress Induces Volume Change and Calcium Transients in Chondrocytes by Transmembrane, Phospholipid, and G-Protein Pathways</article-title>
                  <source>J. Biomech.</source>
                  <year>2001</year>
                  <volume>34</volume>
                  <fpage>1527</fpage>
                  <lpage>1535</lpage>
                  <pub-id pub-id-type="doi">10.1016/S0021-9290(01)00156-7</pub-id>
                  <pub-id pub-id-type="pmid">11716854</pub-id>
                </element-citation>
              </ref>
              <ref id="B42-biomedicines-10-00138">
                <label>42.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sánchez</surname>
                      <given-names>J.C.</given-names>
                    </name>
                    <name>
                      <surname>Danks</surname>
                      <given-names>T.A.</given-names>
                    </name>
                    <name>
                      <surname>Wilkins</surname>
                      <given-names>R.J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Mechanisms Involved in the Increase in Intracellular Calcium Following Hypotonic Shock in Bovine Articular Chondrocytes</article-title>
                  <source>Gen. Physiol. Biophys</source>
                  <year>2003</year>
                  <volume>22</volume>
                  <fpage>487</fpage>
                  <lpage>500</lpage>
                  <pub-id pub-id-type="pmid">15113121</pub-id>
                </element-citation>
              </ref>
              <ref id="B43-biomedicines-10-00138">
                <label>43.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sánchez</surname>
                      <given-names>J.C.</given-names>
                    </name>
                    <name>
                      <surname>Wilkins</surname>
                      <given-names>R.J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Changes in Intracellular Calcium Concentration in Response to Hypertonicity in Bovine Articular Chondrocytes</article-title>
                  <source>Comp. Biochem. Physiol. Part A Mol. Integr. Physiol.</source>
                  <year>2004</year>
                  <volume>137</volume>
                  <fpage>173</fpage>
                  <lpage>182</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.cbpb.2003.09.025</pub-id>
                  <?supplied-pmid 14720602?>
                  <pub-id pub-id-type="pmid">14720602</pub-id>
                </element-citation>
              </ref>
              <ref id="B44-biomedicines-10-00138">
                <label>44.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chao</surname>
                      <given-names>P.H.G.</given-names>
                    </name>
                    <name>
                      <surname>West</surname>
                      <given-names>A.C.</given-names>
                    </name>
                    <name>
                      <surname>Hung</surname>
                      <given-names>C.T.</given-names>
                    </name>
                  </person-group>
                  <article-title>Chondrocyte Intracellular Calcium, Cytoskeletal Organization, and Gene Expression Responses to Dynamic Osmotic Loading</article-title>
                  <source>Am. J. Physiol.-Cell Physiol.</source>
                  <year>2006</year>
                  <volume>291</volume>
                  <pub-id pub-id-type="doi">10.1152/ajpcell.00127.2005</pub-id>
                </element-citation>
              </ref>
              <ref id="B45-biomedicines-10-00138">
                <label>45.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Phan</surname>
                      <given-names>M.N.</given-names>
                    </name>
                    <name>
                      <surname>Leddy</surname>
                      <given-names>H.A.</given-names>
                    </name>
                    <name>
                      <surname>Votta</surname>
                      <given-names>B.J.</given-names>
                    </name>
                    <name>
                      <surname>Kumar</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Levy</surname>
                      <given-names>D.S.</given-names>
                    </name>
                    <name>
                      <surname>Lipshutz</surname>
                      <given-names>D.B.</given-names>
                    </name>
                    <name>
                      <surname>Suk</surname>
                      <given-names>H.L.</given-names>
                    </name>
                    <name>
                      <surname>Liedtke</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Guilak</surname>
                      <given-names>F.</given-names>
                    </name>
                  </person-group>
                  <article-title>Functional Characterization of TRPV4 as an Osmotically Sensitive Ion Channel in Porcine Articular Chondrocytes</article-title>
                  <source>Arthritis Rheum.</source>
                  <year>2009</year>
                  <volume>60</volume>
                  <fpage>3028</fpage>
                  <lpage>3037</lpage>
                  <pub-id pub-id-type="doi">10.1002/art.24799</pub-id>
                  <pub-id pub-id-type="pmid">19790068</pub-id>
                </element-citation>
              </ref>
              <ref id="B46-biomedicines-10-00138">
                <label>46.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>O’Conor</surname>
                      <given-names>C.J.</given-names>
                    </name>
                    <name>
                      <surname>Leddy</surname>
                      <given-names>H.A.</given-names>
                    </name>
                    <name>
                      <surname>Benefield</surname>
                      <given-names>H.C.</given-names>
                    </name>
                    <name>
                      <surname>Liedtke</surname>
                      <given-names>W.B.</given-names>
                    </name>
                    <name>
                      <surname>Guilak</surname>
                      <given-names>F.</given-names>
                    </name>
                  </person-group>
                  <article-title>TRPV4-Mediated Mechanotransduction Regulates the Metabolic Response of Chondrocytes to Dynamic Loading</article-title>
                  <source>Proc. Natl. Acad. Sci. USA</source>
                  <year>2014</year>
                  <volume>111</volume>
                  <fpage>1316</fpage>
                  <lpage>1321</lpage>
                  <pub-id pub-id-type="doi">10.1073/pnas.1319569111</pub-id>
                  <?supplied-pmid 24474754?>
                  <pub-id pub-id-type="pmid">24474754</pub-id>
                </element-citation>
              </ref>
              <ref id="B47-biomedicines-10-00138">
                <label>47.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Yellowley</surname>
                      <given-names>C.E.</given-names>
                    </name>
                    <name>
                      <surname>Jacobs</surname>
                      <given-names>C.R.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Zhou</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Donahue</surname>
                      <given-names>H.J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Effects of Fluid Flow on Intracellular Calcium in Bovine Articular Chondrocytes</article-title>
                  <source>Am. J. Physiol.-Cell Physiol.</source>
                  <year>1997</year>
                  <volume>273</volume>
                  <fpage>C30</fpage>
                  <lpage>C36</lpage>
                  <pub-id pub-id-type="doi">10.1152/ajpcell.1997.273.1.C30</pub-id>
                  <?supplied-pmid 9252439?>
                  <pub-id pub-id-type="pmid">9252439</pub-id>
                </element-citation>
              </ref>
              <ref id="B48-biomedicines-10-00138">
                <label>48.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lee</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Leddy</surname>
                      <given-names>H.A.</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>S.H.</given-names>
                    </name>
                    <name>
                      <surname>Zelenski</surname>
                      <given-names>N.A.</given-names>
                    </name>
                    <name>
                      <surname>Mcnulty</surname>
                      <given-names>A.L.</given-names>
                    </name>
                    <name>
                      <surname>Wu</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Beicker</surname>
                      <given-names>K.N.</given-names>
                    </name>
                    <name>
                      <surname>Coles</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Zauscher</surname>
                      <given-names>S.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Synergy between Piezo1 and Piezo2 Channels Confers High-Strain Mechanosensitivity to Articular Cartilage</article-title>
                  <source>Proc. Natl. Acad. Sci. USA</source>
                  <year>2014</year>
                  <volume>111</volume>
                  <fpage>E5114</fpage>
                  <lpage>E5122</lpage>
                  <pub-id pub-id-type="doi">10.1073/pnas.1414298111</pub-id>
                  <?supplied-pmid 25385580?>
                  <pub-id pub-id-type="pmid">25385580</pub-id>
                </element-citation>
              </ref>
              <ref id="B49-biomedicines-10-00138">
                <label>49.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>D’Andrea</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Vittur</surname>
                      <given-names>F.</given-names>
                    </name>
                  </person-group>
                  <article-title>Propagation of Intercellular Ca<sup>2+</sup> Waves in Mechanically Stimulated Articular Chondrocytes</article-title>
                  <source>FEBS Lett.</source>
                  <year>1997</year>
                  <volume>400</volume>
                  <fpage>58</fpage>
                  <lpage>64</lpage>
                  <pub-id pub-id-type="doi">10.1016/S0014-5793(96)01356-7</pub-id>
                  <pub-id pub-id-type="pmid">9000513</pub-id>
                </element-citation>
              </ref>
              <ref id="B50-biomedicines-10-00138">
                <label>50.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Guilak</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Zell</surname>
                      <given-names>R.A.</given-names>
                    </name>
                    <name>
                      <surname>Erickson</surname>
                      <given-names>G.R.</given-names>
                    </name>
                    <name>
                      <surname>Grande</surname>
                      <given-names>D.A.</given-names>
                    </name>
                    <name>
                      <surname>Rubin</surname>
                      <given-names>C.T.</given-names>
                    </name>
                    <name>
                      <surname>McLeod</surname>
                      <given-names>K.J.</given-names>
                    </name>
                    <name>
                      <surname>Donahue</surname>
                      <given-names>H.J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Mechanically Induced Calcium Waves in Articular Chondrocytes Are Inhibited by Gadolinium and Amiloride</article-title>
                  <source>J. Orthop. Res.</source>
                  <year>1999</year>
                  <volume>17</volume>
                  <fpage>421</fpage>
                  <lpage>429</lpage>
                  <pub-id pub-id-type="doi">10.1002/jor.1100170319</pub-id>
                  <pub-id pub-id-type="pmid">10376733</pub-id>
                </element-citation>
              </ref>
              <ref id="B51-biomedicines-10-00138">
                <label>51.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ohashi</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Hagiwara</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Bader</surname>
                      <given-names>D.L.</given-names>
                    </name>
                    <name>
                      <surname>Knight</surname>
                      <given-names>M.M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Intracellular Mechanics and Mechanotransduction Associated with Chondrocyte Deformation during Pipette Aspiration</article-title>
                  <source>Biorheology</source>
                  <year>2006</year>
                  <volume>43</volume>
                  <fpage>201</fpage>
                  <lpage>214</lpage>
                  <pub-id pub-id-type="pmid">16912394</pub-id>
                </element-citation>
              </ref>
              <ref id="B52-biomedicines-10-00138">
                <label>52.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Burks</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Daniel</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Losse</surname>
                      <given-names>G.</given-names>
                    </name>
                  </person-group>
                  <article-title>The Effect of Continuous Passive Motion on Anterior Cruciate Ligament Reconstruction Stability</article-title>
                  <source>Am. J. Sports Med.</source>
                  <year>1984</year>
                  <volume>12</volume>
                  <fpage>323</fpage>
                  <lpage>327</lpage>
                  <pub-id pub-id-type="doi">10.1177/036354658401200414</pub-id>
                  <pub-id pub-id-type="pmid">6476191</pub-id>
                </element-citation>
              </ref>
              <ref id="B53-biomedicines-10-00138">
                <label>53.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Grimm</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Grosse</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Wehland</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Mann</surname>
                      <given-names>V.</given-names>
                    </name>
                    <name>
                      <surname>Reseland</surname>
                      <given-names>J.E.</given-names>
                    </name>
                    <name>
                      <surname>Sundaresan</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Corydon</surname>
                      <given-names>T.J.</given-names>
                    </name>
                  </person-group>
                  <article-title>The Impact of Microgravity on Bone in Humans</article-title>
                  <source>Bone</source>
                  <year>2016</year>
                  <volume>87</volume>
                  <pub-id pub-id-type="doi">10.1016/j.bone.2015.12.057</pub-id>
                </element-citation>
              </ref>
              <ref id="B54-biomedicines-10-00138">
                <label>54.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Han</surname>
                      <given-names>S.K.</given-names>
                    </name>
                    <name>
                      <surname>Wouters</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Clark</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Herzog</surname>
                      <given-names>W.</given-names>
                    </name>
                  </person-group>
                  <article-title>Mechanically Induced Calcium Signaling in Chondrocytes in Situ</article-title>
                  <source>J. Orthop. Res. Off. Publ. Orthop. Res. Soc.</source>
                  <year>2012</year>
                  <volume>30</volume>
                  <fpage>475</fpage>
                  <lpage>481</lpage>
                  <pub-id pub-id-type="doi">10.1002/jor.21536</pub-id>
                </element-citation>
              </ref>
              <ref id="B55-biomedicines-10-00138">
                <label>55.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Goldring</surname>
                      <given-names>M.B.</given-names>
                    </name>
                  </person-group>
                  <article-title>Immortalization of Human Articular Chondrocytes for Generation of Stable, Differentiated Cell Lines</article-title>
                  <source>Cartilage and Osteoarthritis. Methods in Molecular Medicine</source>
                  <person-group person-group-type="editor">
                    <name>
                      <surname>Sabatini</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Pastoureau</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>De Ceuninck</surname>
                      <given-names>F.</given-names>
                    </name>
                  </person-group>
                  <publisher-name>Humana Press</publisher-name>
                  <publisher-loc>Totowa, NJ, USA</publisher-loc>
                  <year>2004</year>
                  <volume>Volume 100</volume>
                  <fpage>23</fpage>
                  <lpage>35</lpage>
                  <pub-id pub-id-type="doi">10.1385/1-59259-810-2:023</pub-id>
                </element-citation>
              </ref>
              <ref id="B56-biomedicines-10-00138">
                <label>56.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Goldring</surname>
                      <given-names>M.B.</given-names>
                    </name>
                    <name>
                      <surname>Birkhead</surname>
                      <given-names>J.R.</given-names>
                    </name>
                    <name>
                      <surname>Suen</surname>
                      <given-names>L.-F.</given-names>
                    </name>
                    <name>
                      <surname>Yamin</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Mizuno</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Glowacki</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Arbiser</surname>
                      <given-names>J.L.</given-names>
                    </name>
                    <name>
                      <surname>Apperleyll</surname>
                      <given-names>J.F.</given-names>
                    </name>
                  </person-group>
                  <article-title>Interleukin-1 Beta-Modulated Gene Expression in Immortalized Human Chondrocytes</article-title>
                  <source>J. Clin. Investig.</source>
                  <year>1994</year>
                  <volume>94</volume>
                  <fpage>2307</fpage>
                  <lpage>2316</lpage>
                  <pub-id pub-id-type="doi">10.1172/JCI117595</pub-id>
                  <pub-id pub-id-type="pmid">7989586</pub-id>
                </element-citation>
              </ref>
              <ref id="B57-biomedicines-10-00138">
                <label>57.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Böhmer</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Schleiff</surname>
                      <given-names>E.</given-names>
                    </name>
                  </person-group>
                  <article-title>Microgravity Research in Plants</article-title>
                  <source>EMBO Rep.</source>
                  <year>2019</year>
                  <volume>20</volume>
                  <fpage>e48541</fpage>
                  <pub-id pub-id-type="doi">10.15252/embr.201948541</pub-id>
                  <pub-id pub-id-type="pmid">31267713</pub-id>
                </element-citation>
              </ref>
              <ref id="B58-biomedicines-10-00138">
                <label>58.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wuest</surname>
                      <given-names>S.L.</given-names>
                    </name>
                    <name>
                      <surname>Arnold</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Gander</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Zumbühl</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Jost</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Giger-Lange</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Cerretti</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Caliò</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Rattenbacher-Kiser</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Follonier</surname>
                      <given-names>C.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Microtubules and Vimentin Fiber Stability during Parabolic Flights</article-title>
                  <source>Microgravity Sci. Technol.</source>
                  <year>2020</year>
                  <volume>32</volume>
                  <fpage>921</fpage>
                  <lpage>933</lpage>
                  <pub-id pub-id-type="doi">10.1007/s12217-020-09818-8</pub-id>
                </element-citation>
              </ref>
              <ref id="B59-biomedicines-10-00138">
                <label>59.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wright</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Jobanputra</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Bavington</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Salter</surname>
                      <given-names>D.M.</given-names>
                    </name>
                    <name>
                      <surname>Nuki</surname>
                      <given-names>G.</given-names>
                    </name>
                  </person-group>
                  <article-title>Effects of Intermittent Pressure-Induced Strain on the Electrophysiology of Cultured Human Chondrocytes: Evidence for the Presence of Stretch-Activated Membrane Ion Channels</article-title>
                  <source>Clin. Sci.</source>
                  <year>1996</year>
                  <volume>90</volume>
                  <fpage>61</fpage>
                  <lpage>71</lpage>
                  <pub-id pub-id-type="doi">10.1042/cs0900061</pub-id>
                </element-citation>
              </ref>
              <ref id="B60-biomedicines-10-00138">
                <label>60.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Millward-Sadler</surname>
                      <given-names>S.J.</given-names>
                    </name>
                    <name>
                      <surname>Wright</surname>
                      <given-names>M.O.</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>H.S.</given-names>
                    </name>
                    <name>
                      <surname>Caldwell</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Nuki</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Salter</surname>
                      <given-names>D.M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Altered Electrophysiological Responses to Mechanical Stimulation and Abnormal Signalling through A5β1 Integrin in Chondrocytes from Osteoarthritic Cartilage</article-title>
                  <source>Osteoarthr. Cartil.</source>
                  <year>2000</year>
                  <volume>8</volume>
                  <fpage>272</fpage>
                  <lpage>278</lpage>
                  <pub-id pub-id-type="doi">10.1053/joca.1999.0301</pub-id>
                </element-citation>
              </ref>
              <ref id="B61-biomedicines-10-00138">
                <label>61.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wu</surname>
                      <given-names>Q.Q.</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>Q.</given-names>
                    </name>
                  </person-group>
                  <article-title>Mechanoregulation of Chondrocyte Proliferation, Maturation, and Hypertrophy: Ion-Channel Dependent Transduction of Matrix Deformation Signals</article-title>
                  <source>Exp. Cell Res.</source>
                  <year>2000</year>
                  <volume>256</volume>
                  <fpage>383</fpage>
                  <lpage>391</lpage>
                  <pub-id pub-id-type="doi">10.1006/excr.2000.4847</pub-id>
                  <pub-id pub-id-type="pmid">10772811</pub-id>
                </element-citation>
              </ref>
              <ref id="B62-biomedicines-10-00138">
                <label>62.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>van Nueten</surname>
                      <given-names>J.M.</given-names>
                    </name>
                    <name>
                      <surname>Janssen</surname>
                      <given-names>P.A.J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Comparative Study of the Effects of Flunarizine and Cinnarizine on Smooth Muscles and Cardiac Tissues</article-title>
                  <source>Arch. Int. Pharmacodyn. Ther.</source>
                  <year>1973</year>
                  <volume>204</volume>
                  <fpage>37</fpage>
                  <lpage>55</lpage>
                  <?supplied-pmid 4746630?>
                  <pub-id pub-id-type="pmid">4746630</pub-id>
                </element-citation>
              </ref>
              <ref id="B63-biomedicines-10-00138">
                <label>63.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Awouters</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Niemegers</surname>
                      <given-names>C.J.</given-names>
                    </name>
                    <name>
                      <surname>Janssen</surname>
                      <given-names>P.A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Cinnarizine and Flunarizine, Potent Inhibitors of Anaphylactic Shock in Guinea-Pigs</article-title>
                  <source>Arch. Int. Pharmacodyn. Ther.</source>
                  <year>1975</year>
                  <volume>217</volume>
                  <fpage>38</fpage>
                  <lpage>43</lpage>
                  <?supplied-pmid 242287?>
                  <pub-id pub-id-type="pmid">242287</pub-id>
                </element-citation>
              </ref>
              <ref id="B64-biomedicines-10-00138">
                <label>64.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Vincent</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Duncton</surname>
                      <given-names>M.A.J.</given-names>
                    </name>
                  </person-group>
                  <article-title>TRPV4 Agonists and Antagonists</article-title>
                  <source>Curr. Top. Med. Chem.</source>
                  <year>2011</year>
                  <volume>11</volume>
                  <fpage>2216</fpage>
                  <lpage>2226</lpage>
                  <pub-id pub-id-type="doi">10.2174/156802611796904861</pub-id>
                  <?supplied-pmid 21671873?>
                  <pub-id pub-id-type="pmid">21671873</pub-id>
                </element-citation>
              </ref>
              <ref id="B65-biomedicines-10-00138">
                <label>65.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cheung</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Bao</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Behm</surname>
                      <given-names>D.J.</given-names>
                    </name>
                    <name>
                      <surname>Brooks</surname>
                      <given-names>C.A.</given-names>
                    </name>
                    <name>
                      <surname>Bury</surname>
                      <given-names>M.J.</given-names>
                    </name>
                    <name>
                      <surname>Dowdell</surname>
                      <given-names>S.E.</given-names>
                    </name>
                    <name>
                      <surname>Eidam</surname>
                      <given-names>H.S.</given-names>
                    </name>
                    <name>
                      <surname>Fox</surname>
                      <given-names>R.M.</given-names>
                    </name>
                    <name>
                      <surname>Goodman</surname>
                      <given-names>K.B.</given-names>
                    </name>
                    <name>
                      <surname>Holt</surname>
                      <given-names>D.A.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Discovery of GSK2193874: An Orally Active, Potent, and Selective Blocker of Transient Receptor Potential Vanilloid 4</article-title>
                  <source>ACS Med. Chem. Lett.</source>
                  <year>2017</year>
                  <volume>8</volume>
                  <fpage>549</fpage>
                  <lpage>554</lpage>
                  <pub-id pub-id-type="doi">10.1021/acsmedchemlett.7b00094</pub-id>
                  <pub-id pub-id-type="pmid">28523109</pub-id>
                </element-citation>
              </ref>
              <ref id="B66-biomedicines-10-00138">
                <label>66.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Tsien</surname>
                      <given-names>R.Y.</given-names>
                    </name>
                  </person-group>
                  <article-title>A Non-Disruptive Technique for Loading Calcium Buffers and Indicators into Cells</article-title>
                  <source>Nature</source>
                  <year>1981</year>
                  <volume>290</volume>
                  <fpage>527</fpage>
                  <lpage>528</lpage>
                  <pub-id pub-id-type="doi">10.1038/290527a0</pub-id>
                  <pub-id pub-id-type="pmid">7219539</pub-id>
                </element-citation>
              </ref>
              <ref id="B67-biomedicines-10-00138">
                <label>67.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Star</surname>
                      <given-names>A.M.</given-names>
                    </name>
                    <name>
                      <surname>Iannotti</surname>
                      <given-names>J.P.</given-names>
                    </name>
                    <name>
                      <surname>Brighton</surname>
                      <given-names>C.T.</given-names>
                    </name>
                    <name>
                      <surname>Armstrong</surname>
                      <given-names>P.F.</given-names>
                    </name>
                  </person-group>
                  <article-title>Cytosolic Calcium Concentration in Bovine Growth Plate Chondrocytes</article-title>
                  <source>J. Orthop. Res.</source>
                  <year>1987</year>
                  <volume>5</volume>
                  <fpage>122</fpage>
                  <lpage>127</lpage>
                  <pub-id pub-id-type="doi">10.1002/jor.1100050115</pub-id>
                  <pub-id pub-id-type="pmid">3819903</pub-id>
                </element-citation>
              </ref>
              <ref id="B68-biomedicines-10-00138">
                <label>68.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Groden</surname>
                      <given-names>D.L.</given-names>
                    </name>
                    <name>
                      <surname>Guan</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Stokes</surname>
                      <given-names>B.T.</given-names>
                    </name>
                  </person-group>
                  <article-title>Determination of Fura-2 Dissociation Constants Following Adjustment of the Apparent Ca-EGTA Association Constant for Temperature and Ionic Strength</article-title>
                  <source>Cell Calcium</source>
                  <year>1991</year>
                  <volume>12</volume>
                  <fpage>279</fpage>
                  <lpage>287</lpage>
                  <pub-id pub-id-type="doi">10.1016/0143-4160(91)90002-V</pub-id>
                  <pub-id pub-id-type="pmid">1906783</pub-id>
                </element-citation>
              </ref>
              <ref id="B69-biomedicines-10-00138">
                <label>69.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zhang</surname>
                      <given-names>J.H.</given-names>
                    </name>
                    <name>
                      <surname>Chung</surname>
                      <given-names>T.D.Y.</given-names>
                    </name>
                    <name>
                      <surname>Oldenburg</surname>
                      <given-names>K.R.</given-names>
                    </name>
                  </person-group>
                  <article-title>A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays</article-title>
                  <source>J. Biomol. Screen.</source>
                  <year>1999</year>
                  <volume>4</volume>
                  <fpage>67</fpage>
                  <lpage>73</lpage>
                  <pub-id pub-id-type="doi">10.1177/108705719900400206</pub-id>
                  <?supplied-pmid 10838414?>
                  <pub-id pub-id-type="pmid">10838414</pub-id>
                </element-citation>
              </ref>
              <ref id="B70-biomedicines-10-00138">
                <label>70.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zhang</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>X.B.</given-names>
                    </name>
                    <name>
                      <surname>Yang</surname>
                      <given-names>S.Z.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>S.G.</given-names>
                    </name>
                    <name>
                      <surname>Jiang</surname>
                      <given-names>P.D.</given-names>
                    </name>
                    <name>
                      <surname>Lin</surname>
                      <given-names>Z.H.</given-names>
                    </name>
                  </person-group>
                  <article-title>The Effects of Simulated Microgravity on Cultured Chicken Embryonic Chondrocytes</article-title>
                  <source>Adv. Space Res.</source>
                  <year>2003</year>
                  <volume>32</volume>
                  <fpage>1577</fpage>
                  <lpage>1583</lpage>
                  <pub-id pub-id-type="doi">10.1016/S0273-1177(03)90398-X</pub-id>
                  <pub-id pub-id-type="pmid">15002413</pub-id>
                </element-citation>
              </ref>
              <ref id="B71-biomedicines-10-00138">
                <label>71.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Horwitz</surname>
                      <given-names>E.R.</given-names>
                    </name>
                    <name>
                      <surname>Higgins</surname>
                      <given-names>T.M.</given-names>
                    </name>
                    <name>
                      <surname>Harvey</surname>
                      <given-names>B.J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Histamine-Induced Cytosolic Calcium Increase in Porcine Articular Chondrocytes</article-title>
                  <source>Biochim. Et Biophys. Acta (BBA)-Mol. Cell Res.</source>
                  <year>1996</year>
                  <volume>1313</volume>
                  <fpage>95</fpage>
                  <lpage>100</lpage>
                  <pub-id pub-id-type="doi">10.1016/0167-4889(96)00057-2</pub-id>
                </element-citation>
              </ref>
              <ref id="B72-biomedicines-10-00138">
                <label>72.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Becker</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Blase</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Bereiter-Hahn</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Jendrach</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>TRPV4 Exhibits a Functional Role in Cell-Volume Regulation</article-title>
                  <source>J. Cell Sci.</source>
                  <year>2005</year>
                  <volume>118</volume>
                  <fpage>2435</fpage>
                  <lpage>2440</lpage>
                  <pub-id pub-id-type="doi">10.1242/jcs.02372</pub-id>
                  <pub-id pub-id-type="pmid">15923656</pub-id>
                </element-citation>
              </ref>
              <ref id="B73-biomedicines-10-00138">
                <label>73.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cho</surname>
                      <given-names>K.J.</given-names>
                    </name>
                    <name>
                      <surname>Park</surname>
                      <given-names>E.Y.</given-names>
                    </name>
                    <name>
                      <surname>Kim</surname>
                      <given-names>H.S.</given-names>
                    </name>
                    <name>
                      <surname>Koh</surname>
                      <given-names>J.S.</given-names>
                    </name>
                    <name>
                      <surname>Kim</surname>
                      <given-names>J.C.</given-names>
                    </name>
                  </person-group>
                  <article-title>Expression of Transient Receptor Potential Vanilloid 4 and Effects of Ruthenium Red on Detrusor Overactivity Associated with Bladder Outlet Obstruction in Rats</article-title>
                  <source>World J. Urol.</source>
                  <year>2014</year>
                  <volume>32</volume>
                  <fpage>677</fpage>
                  <lpage>682</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00345-013-1099-y</pub-id>
                  <pub-id pub-id-type="pmid">23700140</pub-id>
                </element-citation>
              </ref>
              <ref id="B74-biomedicines-10-00138">
                <label>74.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Caldwell</surname>
                      <given-names>R.A.</given-names>
                    </name>
                    <name>
                      <surname>Clemo</surname>
                      <given-names>H.F.</given-names>
                    </name>
                    <name>
                      <surname>Baumgarten</surname>
                      <given-names>C.M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Using Gadolinium to Identify Stretch-Activated Channels: Technical Considerations</article-title>
                  <source>Am. J. Physiol.-Cell Physiol.</source>
                  <year>1998</year>
                  <volume>275</volume>
                  <fpage>C619</fpage>
                  <lpage>C621</lpage>
                  <pub-id pub-id-type="doi">10.1152/ajpcell.1998.275.2.C619</pub-id>
                  <?supplied-pmid 9688617?>
                  <pub-id pub-id-type="pmid">9688617</pub-id>
                </element-citation>
              </ref>
              <ref id="B75-biomedicines-10-00138">
                <label>75.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rogers</surname>
                      <given-names>T.B.</given-names>
                    </name>
                    <name>
                      <surname>Inesi</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Wade</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Lederer</surname>
                      <given-names>W.J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Use of Thapsigargin to Study Ca2+ Homeostasis in Cardiac Cells</article-title>
                  <source>Biosci. Rep.</source>
                  <year>1995</year>
                  <volume>15</volume>
                  <fpage>341</fpage>
                  <lpage>349</lpage>
                  <pub-id pub-id-type="doi">10.1007/BF01788366</pub-id>
                  <?supplied-pmid 8825036?>
                  <pub-id pub-id-type="pmid">8825036</pub-id>
                </element-citation>
              </ref>
              <ref id="B76-biomedicines-10-00138">
                <label>76.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Koch</surname>
                      <given-names>G.L.E.</given-names>
                    </name>
                  </person-group>
                  <article-title>The Endoplasmic Reticulum and Calcium Storage</article-title>
                  <source>BioEssays</source>
                  <year>1990</year>
                  <volume>12</volume>
                  <fpage>527</fpage>
                  <lpage>531</lpage>
                  <pub-id pub-id-type="doi">10.1002/bies.950121105</pub-id>
                  <?supplied-pmid 2085319?>
                  <pub-id pub-id-type="pmid">2085319</pub-id>
                </element-citation>
              </ref>
              <ref id="B77-biomedicines-10-00138">
                <label>77.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Holmes</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Brogden</surname>
                      <given-names>R.N.</given-names>
                    </name>
                    <name>
                      <surname>Heel</surname>
                      <given-names>R.C.</given-names>
                    </name>
                    <name>
                      <surname>Speight</surname>
                      <given-names>T.M.</given-names>
                    </name>
                    <name>
                      <surname>Avery</surname>
                      <given-names>G.S.</given-names>
                    </name>
                  </person-group>
                  <article-title>Flunarizine A Review of Its Pharmacodynamic and Pharmacokinetic Properties and Therapeutic Use</article-title>
                  <source>Drugs</source>
                  <year>1984</year>
                  <volume>27</volume>
                  <fpage>6</fpage>
                  <lpage>44</lpage>
                  <pub-id pub-id-type="doi">10.2165/00003495-198427010-00002</pub-id>
                  <?supplied-pmid 6141044?>
                  <pub-id pub-id-type="pmid">6141044</pub-id>
                </element-citation>
              </ref>
            </ref-list>
          </back>
          <floats-group>
            <fig position="float" id="biomedicines-10-00138-f001">
              <label>Figure 1</label>
              <caption>
                <p>Graphical scheme of the parabolic flight experiment. (<bold>A</bold>) Scheme of the parabolic flight showing the different flight phases and acceleration. (<bold>B</bold>) Transfection-layout of the 96-well plates with C28/I2 cells. In the left half of the 96-well plate, the cells were transfected with CaMPARI2, while in the right half the cells were transfected with CaMPARI2-F391W. In each half, one LED could be activated at the same time. In each depicted parabola, the first wells illuminated were the GFP (green) transfected cells, followed by the first well of the Pre-Parabola phase, etc. Every well was illuminated for 8 s with 405 nm LEDs with 1.1 W radiant flux.</p>
              </caption>
              <graphic xlink:href="biomedicines-10-00138-g001" position="float"/>
            </fig>
            <fig position="float" id="biomedicines-10-00138-f002">
              <label>Figure 2</label>
              <caption>
                <p>Parabolic flight hardware. (<bold>A</bold>) Flight rack mounted inside Novespace’s aircraft. (<bold>B</bold>) Top view on the functional units, showing the empty payload bays for the two 96-well plates. The spacer with the heating element was removed in the left bay, exposing the LED array. (<bold>C</bold>) Explosion view of the hardware, highlighting the most relevant elements.</p>
              </caption>
              <graphic xlink:href="biomedicines-10-00138-g002" position="float"/>
            </fig>
            <fig position="float" id="biomedicines-10-00138-f003">
              <label>Figure 3</label>
              <caption>
                <p>Time course of photoconversion illumination over 32 s and conversion rates of different CaMPARI2-variants in C28/I2 chondrocyte cells in response to histamine treatment. C28/I2 cells transfected with Lipofectamine 3000 and 100 ng of pMAX_CaMPARI2-F391W-G395D plasmid DNA were treated with 100 µM histamine and illuminated for different durations with 1.1 W 405 nm LEDs. (<bold>A</bold>) C28/I2 chondrocytes imaged by a Zeiss LSM780 laser scanning confocal fluorescence microscope. Scale bar = 200 μm. Green signal: excitation wavelength 488 nm, Argon 25 mW, detection range 490–588 nm, laser intensity: 3%; red fluorescence: excitation wavelength 561 nm, DPSS 561 10 mW, detection range 578–696 nm, laser intensity: 10%; Objective: Plan-Apochromat 10x/0.3 M27; Pinhole size: 2 AU; Pixel pitch: 1.66 µm; Pixel dwell time: 13 µs; Averaging: (8) Red and green fluorescence signals were merged to show the conversion ratio of green to red CaMPARI2. (<bold>B</bold>) The average intensity of red fluorescence divided by green fluorescence fitted with a saturation curve. The yellow area indicates the 90% confidence interval of the saturation curve. (<bold>C</bold>) Cells of the C28/I2 human chondrocyte line were transfected with five different constructs of CaMPARI2 using Lipofectamine 3000. Two days after the transfection, the cells were treated with 100 µM histamine and incubated for 15 s, followed by a 4 s long 405 nm photoconversion light from LEDs with 1.1 W radiant flux. The conversion rate is defined as the percentage of CaMPARI2-transfected cells showing the conversion from green to red fluorescence divided by the total number of fluorescent cells.</p>
              </caption>
              <graphic xlink:href="biomedicines-10-00138-g003" position="float"/>
            </fig>
            <fig position="float" id="biomedicines-10-00138-f004">
              <label>Figure 4</label>
              <caption>
                <p>Conversion rates of C28/I2 human chondrocyte cells expressing GFP, CaMPARI2, or CaMPARI2-F391W. The cells were illuminated for 8 s with 405 nm light during the indicated flight phase for conversion. The cells expressing GFP were illuminated directly before each Pre-Parabola phase. For each parabola and CaMPARI2-construct, eight wells per 96-well plate were treated with 100 µM histamine for 15 s and subsequently illuminated for 8 s. The conversion rate was calculated using the mask described in 2.10. Brackets indicate significant differences compared to the Pre-Parabola phase (<italic toggle="yes">p</italic> &lt; 0.05 using ANOVA and Tukey posthoc tests).</p>
              </caption>
              <graphic xlink:href="biomedicines-10-00138-g004" position="float"/>
            </fig>
            <fig position="float" id="biomedicines-10-00138-f005">
              <label>Figure 5</label>
              <caption>
                <p>High throughput fluorescence microscopy workflow of C28/I2 human chondrocyte cell line transfected with CaMPARI2-F391W. (<bold>A</bold>) The IncuCyte S3 high-throughput microscope of Sartorius took five images per well of 96-well plates. The shown cells were treated with 100 µM histamine directly after the parabolic flight and were illuminated for 8 s by photoconversion light 15 s after the histamine stimulus. The centered image (red frame in (<bold>A</bold>)) was used as an example to show the mask created with the IncuCyte 2021A software in (<bold>B</bold>,<bold>D</bold>). (<bold>B</bold>,<bold>D</bold>) Green and Red fluorescence of CaMPARI2-F391W is depicted as an orange merge. The red frame is the image section displayed in (<bold>C</bold>,<bold>E</bold>). (<bold>C</bold>,<bold>E</bold>) Cells only identified as green fluorescent are circled cyan. Cells only identified as red fluorescent are circled purple. Cells identified by the IncuCyte mask as green and red fluorescent are colored white. The scales in (<bold>B</bold>,<bold>C</bold>) represent 500 µm; the scales in (<bold>D</bold>,<bold>E</bold>) represent 100 µm.</p>
              </caption>
              <graphic xlink:href="biomedicines-10-00138-g005" position="float"/>
            </fig>
            <fig position="float" id="biomedicines-10-00138-f006">
              <label>Figure 6</label>
              <caption>
                <p>Conversion rates of cells transfected with CaMPARI2-F391W and subjected to a parabolic flight. Eight 96-well plates were used for each of the three parabolic flights. Each plate was treated with one of the displayed drugs 5 h before photoconversion. The cells were illuminated over four parabolas (0, 10, 20, and 30). A conversion rate was calculated for each flight phase and the histamine post-flight control (<italic toggle="yes">n</italic> = 12, 3 flights, 4 parabolas) using the IncuCyte 2021A mask described in 2.10. Brackets indicate significant differences compared to the Pre-Parabola phase (<italic toggle="yes">p</italic> &lt; 0.05 using ANOVA and Tukey posthoc tests).</p>
              </caption>
              <graphic xlink:href="biomedicines-10-00138-g006" position="float"/>
            </fig>
            <fig position="float" id="biomedicines-10-00138-f007">
              <label>Figure 7</label>
              <caption>
                <p>Conversion rates of C28/I2 cells transfected with CaMPARI2-F391W and treated with selected drugs. Immediately after the parabolic flights, cells were treated for 15 s with 100 µM histamine and subsequently illuminated for 8 s with 405 nm light. Asterisks indicate significant change compared to Untreated (<italic toggle="yes">p</italic> &lt; 0.05 using ANOVA and Tukey posthoc tests). Untreated, DMSO-control, gadolinium chloride, and ruthenium red had no significant effect on the conversion rate of CaMPARI2-F391W after treatment with histamine. GSK2193874 reduced the conversion efficiency by 50% compared to untreated cells, whereas Thapsigargin and Flunarizine completely inhibited the conversion of CaMARI2-F391W. The conversion rate of the Pre-Parabola phase as a base conversion of each inhibitor was subtracted from the conversion rates. Asterisks indicate significant differences compared to cells only treated with Histamine (untreated) (<italic toggle="yes">p</italic> &lt; 0.05 using ANOVA and Tukey posthoc tests).</p>
              </caption>
              <graphic xlink:href="biomedicines-10-00138-g007" position="float"/>
            </fig>
            <fig position="float" id="biomedicines-10-00138-f008">
              <label>Figure 8</label>
              <caption>
                <p>Z’-Factor analysis based on all four parabolas of the first parabolic flight day. CaMPARI2-F391W transfected human C28/I2 chondrocytes were treated with 100 µM histamine to induce photoconversion of CaMPARI2-F391W with 405 nm light. In addition, the Histamine + BAPTA condition was pretreated with 10 µM of the calcium (Ca<sup>2+</sup>) chelator BAPTA-AM as a negative control. The calculated Z’-factor for the first flight day is 0.72.</p>
              </caption>
              <graphic xlink:href="biomedicines-10-00138-g008" position="float"/>
            </fig>
            <fig position="float" id="biomedicines-10-00138-f009">
              <label>Figure 9</label>
              <caption>
                <p>Transporters and receptors involved in calcium (Ca<sup>2+</sup>)-signalling and inhibitors used during the 75th ESA parabolic flight campaign. Blunted-head arrow show inhibiton of transporters and pumps by its associated drug, normal arrows show molecule movement through transporters or in signal cascades. H1R: Histamine H<sub>1</sub> receptor; IP3: Inositol trisphosphate; IP3R: Inositol trisphosphate receptor; PIP2: Phosphatidylinositol 4,5-bisphosphate; PLC: Phospholipase C; RyR: Ryanodine receptors; SERCA: Sarco/endoplasmic reticulum Ca<sup>2+</sup>-ATPase; SOCC: Store-operated Ca<sup>2+</sup> channel; TRPV4: Transient receptor potential cation channel subfamily V member 4; VGCC: Voltage-gated Ca<sup>2+</sup> channel. This figure was created with <uri>BioRender.com</uri> (accessed on 5 January 2022).</p>
              </caption>
              <graphic xlink:href="biomedicines-10-00138-g009" position="float"/>
            </fig>
            <table-wrap position="float" id="biomedicines-10-00138-t001">
              <object-id pub-id-type="pii">biomedicines-10-00138-t001_Table 1</object-id>
              <label>Table 1</label>
              <caption>
                <p>Drugs applied during the experiment.</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Drug</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Concentration</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Solvent</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Action</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Reference</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Untreated</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DMSO</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.1%</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DMSO control</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gadolinium (III) chloride (Gd<sup>3+</sup>)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10 µM</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">H<sub>2</sub>O</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Blocker of extracellular calcium (Ca<sup>2+</sup>) entry</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B38-biomedicines-10-00138" ref-type="bibr">38</xref>,<xref rid="B40-biomedicines-10-00138" ref-type="bibr">40</xref>,<xref rid="B41-biomedicines-10-00138" ref-type="bibr">41</xref>,<xref rid="B46-biomedicines-10-00138" ref-type="bibr">46</xref>,<xref rid="B49-biomedicines-10-00138" ref-type="bibr">49</xref>,<xref rid="B59-biomedicines-10-00138" ref-type="bibr">59</xref>,<xref rid="B60-biomedicines-10-00138" ref-type="bibr">60</xref>,<xref rid="B61-biomedicines-10-00138" ref-type="bibr">61</xref>]</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Thapsigargin</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 µM</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.1% DMSO</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Blocker of SERCA (sarco/endoplasmic reticulum Ca<sup>2+</sup>-ATPase)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B47-biomedicines-10-00138" ref-type="bibr">47</xref>]</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Flunarizine</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50 µM</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.1% DMSO</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Blocker of Ca<sup>2+</sup> entry and histamine H1</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B62-biomedicines-10-00138" ref-type="bibr">62</xref>,<xref rid="B63-biomedicines-10-00138" ref-type="bibr">63</xref>]</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ruthenium red</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10 µM</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">H<sub>2</sub>O</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Blocker of CatSper1, KCNK3, RyR1, RyR2, RyR3, TRPM6, TRPM8, TRPV1, TRPV2, TRPV3, TRPV4, TRPV5, TRPV6, TRPA1, CALHM1, TRPP3, PIEZO</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B64-biomedicines-10-00138" ref-type="bibr">64</xref>]</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GSK2193874</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10 µM</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.1% DMSO</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Selective blocker of TRPV4</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B65-biomedicines-10-00138" ref-type="bibr">65</xref>]</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BAPTA-AM</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10 µM</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.1% DMSO</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cell-permeable Ca<sup>2+</sup>-chelator</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B66-biomedicines-10-00138" ref-type="bibr">66</xref>]</td>
                  </tr>
                </tbody>
              </table>
            </table-wrap>
            <table-wrap position="float" id="biomedicines-10-00138-t002">
              <object-id pub-id-type="pii">biomedicines-10-00138-t002_Table 2</object-id>
              <label>Table 2</label>
              <caption>
                <p>Photoconversion metrics.</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Metric</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Definition</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Conversion rate</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The proportion of the green fluorescent cells that also display a red fluorescence (photoconversion)</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Red objects mean fluorescence intensity</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The mean red intensity of all cells</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Merged objects red mean intensity</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The mean red intensity of all cells displaying green and red fluorescence</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Red-integrated intensity per well</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The red intensity per well divided by the number of cells per well that display green and red fluorescence</td>
                  </tr>
                </tbody>
              </table>
            </table-wrap>
          </floats-group>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
